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A B S T R A C T 
Local glucocorticoid injection has been used to reduce inflammation for many years. 
Although glucocorticoids are known to have a strong anti-inflammatory activity, they 
also inhibit the metabolism of many cell types. Controversy concerning the use of 
glucocorticoids for local injection of soft tissue began with multiple case reports of 
spontaneous tendon rupture following such treatment. The observed incidence of 
tendon rupture in patients treated with glucocorticoids, although rare, suggested that 
glucocorticoid might alter tendon fibroblast metabolism. Although numerous animal 
studies have been performed on the effects of glucocorticoids, there is no in vitro 
study on the direct cellular effect of glucocorticoids on tendon and no agreement has 
been reached with regard to the etiology of spontaneous tendon rupture. Whether 
glucocorticoids predispose certain patients to tendon rupture and its mechanism is 
not fully understood. 
The objective of this study was to investigate the effects of dexamethasone on human 
tendon fibroblasts in vitro and the effect of PDGFBB in counteracting such inhibition. 
In this study, cell culture model was used because it can provide a more homogenous 
environment for studying the direct effect of glucocorticoids on human patellar 
tendon fibroblasts. Besides, PDGFBB was chosen for counteracting the inhibitory 
effects produced by glucocorticoids because it is a well-known mitogen and 
chemoattractant for tendon fibroblasts. Tendon fibroblasts were obtained by an 
explant method and cultured in vitro using culture medium supplemented with 10% 
fetal bovine serum and cells from passage one to three were used. 
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It was shown that cells cultured with dexamethasone (ljuM) became flattened, 
polygonal and diminished intercellular contacts. When tendon fibroblasts cultured in 
medium with various concentrations of dexamethasone (0.001, 0.01，0.1, 1, 10, 
lOOjLiM), there was a significant decrease in viable cell number measured by MTT 
assay (p<0.001,n=10) and cell proliferation measured by BrdU incorporation assay 
(p<0.001,n=10). Both decreased significantly in dose-dependent manner compared 
with those in the control group. However no apoptosis was detected in 
dexamethasone-treated cultures in all concentrations (n=5). Besides, dexamethasone 
(l|iM) could also inhibit both collagen (p<0.001,n=8) and proteoglycan syntheses 
(p=0.001,n=10) when measured by radioactive labeling. It could also induce finer 
collagen fibril secretion, when examine the collagen fibrils under scanning electron 
microscope. 
On the other hand, addition of PDGFBB (lOng/ml) to the cultures could significantly 
increase viable cell number (p=0.001,n=10), proliferation (p=0.002,n=10)，collagen 
synthesis (p=0.0031, n=8) and proteoglycan synthesis (p=0.001,n=10). And bundles 
of collagen fibrils were observed under scanning electron microscope in the presence 
of PDGFBB. 
When cells were co-cultured with dexamethasone (Ij^M) plus PDGFBB (lOng/ml), 
dexamethasone-induced inhibitory effect on viable cell number, cell proliferation, 
collagen and proteoglycan syntheses were diminished. Besides, from the result of 
immunocytochemistry staining, we found that dexamethasone would reduce the 
expression ofPDGF-P receptor while PDGFBB could up-regulate this receptor level. 
Therefore, we postulate that this might be one of the possible mechanisms by which 
viii 
dexamethasone exerted deleterious effect on tendon fibroblasts. And PDGFBB could 
protect the fibroblasts and hence could be used to counteract these side effects of 
dexamethasone in vitro. In conclusion, the reduction in cell proliferation coupled 
with the inhibition of collagen and proteoglycan syntheses in dexamethasone-treated 
culture may explain the change in the mechanical properties and hence predispose 
tendon to rupture. Our study has demonstrated a poor study area and the research 
outcome have confirmed a deleterious effect of glucocorticoids on human tendon 
fibroblasts in vitro. On the other hand, PDGFBB seemed to reverse the inhibitory 
effects induced by dexamethasone and protect the tendon form deterioration. Further 
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CHAPTER I INTRODUCTION 
1.1 Background 
Tendon functions to transmit muscle force to skeletal system and so it is often 
involved in physical movement. One of the treatments for inflammation is 
glucocorticoid injection which gives rapid pain relieves. Unfortunately, case reports 
on spontaneous tendon ruptures with previous glucocorticoid treatment were noticed 
over the past 50 years (Kleinman et al 1983; Melmed EP 1965; Smaill GB 1961). 
Although scientists have attempted to correlate between glucocorticoids 
administration and tendon rupture, the etiology of this disorder could not be drawn. 
This may be due to the use of in vivo model which is a complicated system to show 
the direct effect relationship. Moreover, the use of animal tissue other than human 
tissue does not allow conclusion in human conditions. Recently, Yu and his group 
started to examine this problem by using the human specimen, but their study was 
restricted to fibroblast proliferation and procollagen synthesis on ligament instead of 
tendon (Yu et al 1999). Therefore, in the present study, human tendon fibroblasts and 
in vitro model were used in order to show the direct effect of dexamethasone on 
tendon cellular metabolism. The establishment of the cause-effect relationship may 
provide more guideline for the use of glucocorticoid injection on tendon clinically. 
After determining the deleterious side effect of dexamethasone on human tendon 
fibroblast, the feasibility of utilizing platelet-derived growth factor isoform B 
(PDGFBB) for counteracting the effect of dexamethasone was also examined. The 
result would be useful clinically to protect the tendons and allow the judicious use of 
glucocorticoid injection therapy. 
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1.2 Tendon 
The word tendon comes from the Latin tendere (to stretch out). It is one kind of 
connective tissue, which performs mechanical functions. 
1,2,1 Structure and Function 
Tendon consists of collagen and elastin embedded in a proteoglycan-water matrix, 
with collagen accounting for 65-70% and elastin approximately 2% of the dry mass 
of the tendon (Jozsa and Kannus 1997). Soluble troprocollagen molecule form cross-
links to create collagen fibrils which can be visualized under the electron microscope. 
These collagen subunits are internally bound by a matrix of proteoglycans and 
glycosaminoglycans (Fig.l). A bunch of collagen fibrils forms a collagen fiber, 
which is the basic unit of a tendon. Tendons appear white because they do not 
contain an internal vascular network. 
3 
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Collagen fibril Collagen fiber Primary fiber bundles 
Proteoglycans and 
Transverse I I ； 舉 堪 趣 诛 | 
\ el®^ 念零I� 
Figure 1. A schematic diagram of a collagen fibril, collagen fiber and primary 
fiber bundles (Jozsa LG 1997). 
Within a fiber, proteoglycans and glycosaminoglycans surround the collagen fibrils. 
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Collagen fibrils are bundled into fascicles containing blood and lymphatic vessels as 
well as nerves. The fascicles are grouped together, surrounded by epitenon, and form 
the gross structure of the tendon, which is further enclosed by paratenon, separated 
from the epitenon by a thin layer of fluid to allow tendon movement with reduced 
friction (Fig.2). 
Primary Secondary Tertiary Tendon 




Figure 2. The hierarchical organization of the tendon structure from collagen 
fibrils to the entire tendon (Jozsa LG 1997). 
Tendons contain no contractile units and therefore cannot generate force; instead 
they are designed to pull and transmit force from muscles to bone. This function is 
primarily achieved through the collagen, the most abundant protein in tendon. 
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1.2,2 Tendon Fibroblast 
Fibroblasts are the only cells present in the tendon arranged in columns between the 
collagen fibers. The word “fibroblasts，，is a generic term for a population of cells 
responsible for the establishment, maintenance and repairment of three-dimensional 
form in multicellular organisms. Their functions include the deposition, maintenance, 
degradation and rearrangement of the extracellular matrix. And the normal 
composition, structure and mechanical properties of the tendons depend on the 
maintenance of a balance between matrix degradation and matrix synthesis. 
Connective tissue cells such as tendon fibroblasts, produce and secrete an array of 
macromolecules, forming a complex network filling the extracellular space of the 
submucosa, called the extracellular matrix (ECM). The ECM is not only a 
scaffolding having a mechanical role in supporting and maintaining tissue structure, 
but it is a complex and dynamic meshwork influencing many biologic cell functions 
such as development, migration, and proliferation. It is a dynamic structure. 
Equilibrium between synthesis and degradation of ECM components is required for 
the maintenance of its homeostasis. As yet, there is no generally accepted phenotype 
denoting a “tendon cell" which identifies it as a unique, specific cell type, although 
they are present in most tissues of the organisms. Primary cultures from different 
species and tissues may response differently. For instance, human skin fibroblast 
grew more rapid but senesce more slowly than tendon fibroblast (Evans et al 1998). 
However, in rabbit primary culture, opposite result was obtained. 
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1.2,3 Components of the Extracellular Matrix 
The extracellular matrix is a complex of macromolecules surrounding stromal cells 
and underlying epithelia. More than simply an inert structural support, it contains 
information that modulates cell behavior, migration, attachment and differentiation. 
Thus, it has profound effects on morphogenesis and repair. The extracellular matrix 
consists of 3 major classes of macromolecules: the collagen, proteoglycan, and the 
non-collagenous structural glycoprotein. Collagen is reported to comprise 
approximately 65-70% of the tendon dry mass (Jozsa and Kannus 1997). Of the 
remaining substances, most are proteoglycans, while approximately 2% are non-
collagenous structural glycoprotein (such as elastin), and less than 2% are inorganic 
components (such as copper and calcium). 
7 
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1.2.3,1 Collagen 
The collagen fibers in connective tissue are one of the principle structural elements, 
synthesized by fibroblast. It makes up of 65-70% of the dry mass of tendon. 
Biochemical, microscopic and immunohistochemical studies have identified some 19 
different types (I to XIX) in various connective tissues (Prockop et al 1995). 
Collagen is the major matrix protein of tendon, consisting of >95% type I collagen, 
with lesser amounts of other types including collagen type III (Riley et al 1994). 
Each type I molecule is the hetertrimer [al(I)2a2(I)]，being composed of two a 1(1) 
chains and one a2(I) chain. This type of collagen possesses high tensile strength with 
limited elasticity, therefore suitable to perform the load-bearing function. Alterations 
in the metabolism of fibroblasts, by local stimuli with growth factors (Allampallam 
et al 2000), or glucocorticoids (Oikarinen et al 1991) have an influence on the 
quantity, type, and stability of the collagen in the tendon. The chemical composition 
of collagen responsible for its biological function of being the bonding components, 
which holds tissues together. 
8 
CHAPTER I INTRODUCTION 
1.2,3.2 Proteoglycan 
Proteoglycan is another important component of the tendon matrix. It is composed of 
a core protein attached with various glycosaminoglycans (GAGs). Although it is not 
abundant in such tissue, it is very important in resisting shear and compression by its 
great capacity of absorbing water. Moreover, it is also involved in the assembly of 
the collagen fibers, interactions between cell and matrix, cell differentiation, 
functions as growth factor co-receptor and cell proliferation. The 5 main classes of 
GAGs are hyaluronic acid (HA), chondrotin sulphate (CS), dermatan sulphate (DS), 
keratan sulphate (KS) and heparin sulphate (HS). GAGs occur to differing extents in 
different tissues, presumably because their individual properties influence the 
behavior of the matrix. In tendon, the major GAG is dermatan sulphate (Rosenberg 
et al 1986; Scott et al 1989). 
Electron microscopic studies showed that DS is distributed throughout the 
extracellular matrix of connective tissues in the space between collagen fibrils. It has 
distinctive biochemical properties that affect the function, organization, stability and 
biologic properties of connective tissue. For instance, it may influence collagen fibril 
formation during tendon and ligament repair. Proteoglycan, together with water, 
provides lubrication and spacing that are crucial to the gliding function at intercept 
points where fibers cross the tissue matrix. 
9 
CHAPTER I INTRODUCTION 
1.2.3.3 Non-Collagenous Structural Glycoproteins 
This class includes fibronectin, laminin, entactin, osteonectin, tenascin and elastin. 
They are less abundant than collagen and proteoglycan in tendons. However, they 
also have their specific role, for instance, fibronectin has roles in development and in 
wound healing; laminin has roles in cell motility and migration; osteonectin has roles 
in binding the mineral and collagen components of bone; tenascin has roles in 
chrondrogenesis and osteogenesis; and elastin provides tensile strength of the tendon. 
10 
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1.3 Inflammatory Disorders of Tendon 
1.3,1 Inflammation 
Inflammation is a dense reaction of higher animals due to the presence of injurious 
stimulus. It is commonly observed in musculoskeletal disorder. It is a complex 
vascular, cellular, biochemical event necessary to the healing and repair process. The 
classic clinical manifestations of inflammation are swelling, increased temperature, 
erythema, pain and loss of function (Fig.3). Inflammatory reactions often result from 
undue pressure on the soft tissue, friction between soft tissue planes, repeated load or 
overload, or from external trauma. These inflammatory reactions include arthritis, 
tendonitis, synovitis and bursitis. 
A . z ^ ^ ^ • Cytokines 
n n ： ^ A 汉 、 二 ： 一 
^ 乂 V z - v • Proteinases 
© — . Free 
U ^ Radicals 
Adhesion Migration 
Heat Swelling Pain 
Redness Tissue destruction 
Figure 3. The inflammatory process (Doherty et al 1995). 
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1.3.2 Treatment 
Clinical treatment of inflammation includes rest; non-steroidal anti-inflammatory 
medications, physical modalities such as heat, ice and ultrasound, and systemic or 
local steroid administration. Among these, glucocorticoid injection provides the rapid 
response with less systemic side effects. 
1.3.2.1 Glucocorticoid as an Anti-inflammatory Drug 
Glucocorticoid, first introduced by Philip Hench and associates in the 1949 for the 
treatment of rheumatoid condition. He reported the astounding observation that 
administrating an adrenocortical glucocorticoid to a patient with progressive, active 
rheumatoid arthritis stopped the disease dead in its tracks (Hench et al 1949). Later 
on they are being used frequently in clinical practice, because of their known rapid 
anti-inflammatory actions and pain-relief. They can inhibit early inflammatory 
events such as edema, capillary dilatation, lymphocyte circulation into inflamed area 
and phagocytotic activity. As such, the inflammatory symptoms such as local heat, 
redness, swelling and tenderness can be reduced. Especially in rheumatoid arthritis, 
intra-articular and peritendinous injections of glucocorticoid have achieved 
widespread acceptance for the treatment of this disease. 
The common glucocorticoids used for the inhibition of inflammation include 
dexamethasone, betamethasone, hydrocortisone, triamcinolone, cortisone, 
methylprednisolone and prednisone. They can exert suppressive effects on the 
12 
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production of a protein called lipocortins, which inhibits phospholipase A2 (PLA2). 
Regulation of intracellular PLA2 is important for stimulating arachidonic acid release 
during inflammatory reactions. PLA2 plays a critical role in the overall regulation of 
eicosanoid production, since the activity of subsequent metabolic steps is limited of 
eicosanoid production. And this is thought to be a primary mechanism by which 
these hormones exert their anti-inflammatory effects. Thus they can prevent the 
initials events of inflammation, including capillary dilation, migration of 
inflammatory cells, release of inflammatory mediators and production of cytokines 
(Leech et al 1999). The suppression of these cellular activities will dramatically 
decreases the heat, erythema, swelling and pain during inflammation. Moreover, it 
has been reported that glucocorticoid injection could significantly reduce both the 
diameter and tenderness of inflamed tendon in 9 patients indicating that it is an 
effective anti-inflammatory drug (Fredberg et al 1998). Therefore, these hormones 
gained a remarkable reputation for their effectiveness in the treatment of a wide 
range of inflammatory disorders. 
Membrane phospholipids 
Glucocorticoid inhibit 
Arach donic acid 
T 
Cyclooxygenase pathway . � Lipoxygenase pathway 
PGE2，PGD2, PGF2a, my Leukotrienes 
(vasodilation) j c ^ ^ 
Figure 4. Inhibitory pathway of glucocorticoid on inflammatory respond. 
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1.3,2.2 Dexamethasone 
(9a-Fluoro-lip, 17a, 21-trihydroxy-16a-methylpregna-l,4-diene-3,20-dione^ 
Individual glucocorticoid varies considerably with regard to their potency. In general, 
the catabolic and anti-inflammatory potencies were "roughly related，，，with 
dexamethasone having more than twenty-five times the biopotency than Cortisol. In 
1962, Perlman and his group studied the effects of fluorinated glucocorticoids such 
as dexamethasone and non-fluorinated glucocorticoids as well as of different 
progesterone derivatives. They concluded that the addition of a fluorine atom to the 
molecule increases its toxicity, an effect which is independent on the presence of 
other chemical substituents in the glucocorticoid structure. So, the inhibitory effect 
that certain glucocorticoids possessed on fibroblast growth can be related to their 
anti-inflammatory action in vivo generally. Dexamethasone, a catabolic and high 
potency glucocorticoid, can be used for all conventional indications for 
glucocorticoids. Although it is more commonly used in systemic medication and less 
frequently used in local injection, it is commonly used in research study. Therefore, 
dexamethasone was chosen for this study. 
H O C O C H ^ O H 
H > — 
F 
Figure 5. Structure of dexamethasone. 
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1.3.3 Clinical Occurrence of Tendon Rupture 
Soon after the discovery of the therapeutic potential of glucocorticoids, their adverse 
effects on soft tissue became evident. Two common complications were osteoporosis 
and degradation of soft tissue structures such as tendons and ligaments (McWhorter 
et al 1991). Previous reports have highlighted the possible complication of tendon 
rupture associated with glucocorticoid injections of the patellar tendon (Clark et al 
1995; Morgan et al 1974)，Achilles tendon (Chechick et al 1982; Kleinman et al 1983; 
Unverferth et al 1973; Bedi et al 1970), triceps tendon (Stannard et al 1993) and the 
common extensor tendons (Smith et al 1999). Both local and systemic glucocorticoid 
administrations have been implicated in (Unverferth et al 1973). 
Up to date, there has been conflicting evidence as to the role of glucocorticoids in 
these pathologies, especially in tendon rupture. Early in 1970, one case report of 
spontaneous tendon ruptures after local glucocorticoid injection (Bedi et al 1970). 
They suspected that glucocorticoid treatment might delay the maturation of the 
fibrous tissues due to their anti-inflammatory effect, and also the tensile strength of 
the tendon. Thus causing it to rupture on minimal effort. Another report on Achilles 
tendon rupture also agreed that glucocorticoid treatment induced pain relief shortly 
and permitted the patient to sport activity too early (Chechick et al 1982). Similar 
study done by Unverferth had more focus on the mechanical properties (Unverferth 
et al 1973). They found that 7 cases of tendon rupture after receiving repeated local 
glucocorticoid injection, although all had brief symptomatic improvement following 
the injections. They then investigated the validity of the clinical impression by using 
rabbit animal model. In their study, they found that tendons of rabbits from the 
15 
CHAPTER I INTRODUCTION 
glucocorticoid-treated group demonstrated disruption of the collagen bundle and 
decreased in tensile strength. He finally concluded that glucocorticoid injection not 
only decreased the tensile strength of tendon but also masked the symptoms and 
therefore patients returned to heavy activity prematurely. 
Later, one study reported 4 cases of tendon rupture of rheumatic diseases (Kaipman 
et al 1980). They concluded that tendon rupture appeared to have occurred more 
often in patients who have received local glucocorticoid injections than in those who 
have not. Another case report of tendon rupture after glucocorticoid injection found 
that all 3 patients have no preceding history of chronic pain or disability, and so 
eliminated the hypothesis of the pre-existing tendinitis (Kleinman et al 1983). 
Therefore, it is not likely that tendon disorders play a critical role in this aspect. 
In 1991，Newnham has reported 10 patients ruptured their Achilles tendon after oral 
glucocorticoids treatment (Newnham et al 1991). In every case the rupture occurred 
while they were walking on level ground, but not exercising heavy activity. Some of 
them were bilateral rupture while some were uni-lateral rupture. They concluded that 
long-term glucocorticoid treatment (ten-year) predisposed the patient to an increased 
risk of non-traumatic rupture of the tendon. Similar with this, a patient have more 
than 10 years administration of glucocorticoid was reported in simultaneous bilateral 
quadriceps rupture (David et al 1995). And recently, Stannard reported one case of 
tendon rupture with medical record of olecranon bursitis that had been treated with 
numerous local glucocorticoid injections, as well as a history of glucocorticoid abuse 
(Stannard et al 1993). He then hypothesized that oral glucocorticoid abuse might also 
have detrimental effect on the mechanical properties of connective tissue. Therefore, 
16 
CHAPTER I INTRODUCTION 
it seems that oral and long-term administrations of glucocorticoid are also associated 
with tendon rupture. 
Despite this uncertainly, most orthopaedic, rheumatology and sports medicine 
textbooks condemn local glucocorticoid injections around the tendon, do responsible 
for secondary tendon ruptures. As proof of their deleterious effects, histological 
changes of tendon specimen after glucocorticoid injections was examined, Clark 
found that non-specific changes scantly fibroblasts and blood vessels were confirmed 
(Clark et al 1995). However, another study showed fibrillary degeneration of 
collagen fibrous tissue, fibrinous exudate, minimal organization and no regenerative 
activity (Smith et al 1999). They then hypothesized that glucocorticoid injection 
caused collagen degeneration, which had become fibrillary, and the absence of 
regenerative response. It may predispose the tendon to rupture. 
Grouping together, there is no objective evidence in any of these references to 
suggest that tendon ruptures be caused by glucocorticoids administration. 
Nevertheless, some common evidence can be drawn: local or oral administration of 
glucocorticoid, single dose or repeated doses can cause complication such as tendon 
rupture. This complication is not likely to be associated with the pre-existing tendon 
disorders. However, the anti-inflammatory effect of the drug may mask the 
underlying disease and so increase the risk of overuse. 
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1,3,4 Animal Research related to Glucocorticoids and Tendon Rupture 
Glucocorticoid receptor is widely distributed in human tissues, but receptor 
activation and regulation are tissue-specific. Effects of glucocorticoids differed 
depending on the cell types. For instance, glucocorticoid inhibited cell growth in skin 
fibroblast (Ponec et al 1977), while it stimulated cell growth in human keratocytes 
(Bourcier et al 1999). Therefore, fibroblasts from different sources may have varying 
synthetic and metabolic capabilities. In this study, only tendon fibroblast was chosen 
for examination. 
Similar to the clinical observation, animal study on glucocorticoids administration 
has been associated with both systemic and local complications. The most commonly 
reported local complications of glucocorticoid injections include subcutaneous fat 
necrosis, loss of skin pigmentation, tendon rupture (Bedi et al 1970; Chechick et al 
1982; Kleinman et al 1983; Melmed EP 1965; Newnham et al 1991 and Smaill GB 
1961) and osteolysis. 
Although some experimental works have investigated the risk of degeneration of 
tendon tissue altered by glucocorticoids (Kapetanous G 1982; Unverferth et al 1973). 
And it was shown that the damage associated with the injection of glucocorticoids 
was more severe than that associated with the injection of saline solution (Unverferth 
et al 1973). However, the roles of glucocorticoids in accelerated degeneration of 
tendon tissues remain uncertain and many factors undoubtedly contribute to these 
clinical problems. 
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Evidence that glucocorticoid induces tendon pathology can be gathered from the 
observations of abnormalities in the ultrastructure of collagen fibrils after a period of 
glucocorticoid consumption. In one study, the glucocorticoid-treated mice exhibited 
increased in the presence of collagen dysplasia in collagen fibrils and this could 
directly decrease the tensile strength of tendon (Michna H 1986). Furthermore, the 
increase in the frequency of dysplastic collagen fibrils was determined to be directly 
proportional to the duration of anabolic glucocorticoid administration. 
Studies of the effect of glucocorticoid injections on the mechanical properties of 
normal tendons have yielded inconsistent results. Some of the inconsistency may 
have resulted from differences in the doses of glucocorticoids, the location of the 
injection (injection into the tissues surrounding the tendon compared with injection 
into the tendon directly), the time of testing after the injection, and the methods of 
measuring the strength of the tendon. One study performed by Unverferth has 
compared the Achilles tendon strength of two groups of rabbits. One group was 
injected with glucocorticoid and the other with saline solution. The results showed a 
significant decrease in tensile strength in the group injected with glucocorticoids 
(Unverferth et al 1973). Another researcher studied the change of biomechanical 
properties related to the glucocorticoid treatment on rat tendon. Their result showed 
that tendon elongation would be increased at a particular stress in glucocorticoid-
treated group, also muscular contraction would necessarily be increased to produce 
this stress (Wood et al 1988). Because of these events, complete tendinous failure 
may result. Besides, change in crimp morphology by glucocorticoid has also been 
reported and this may alter the rupturing strain of tendon and the normal 
biomechanics of the extremities (Wood et al 1988; Laseter et al 1991). 
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However, several investigators have found that injections of glucocorticoids did not 
weaken normal tendons (Matthew et al 1975; Phelps et al 1974). For instance, Phelps, 
in his study on the tensile strength of the patellar tendon of rabbits after multiple 
injections of methylprednisolone, found no alternations in the mechanical properties 
of the tendon injected with glucocorticoids (Phelps et al 1974). He concluded that 
tendon rupture in athlete could stem from some underlying pathological process and 
not to a destructive process initiated by the glucocorticoid injection. In contrast, 
another study showed the ultimate strength at failure of normal Achilles tendons in 
rabbits decreased 35 per cent forty-eight hours after glucocorticoid injection 
(Kennedy et al 1976). Histological examination of the injected tendons showed 
evidence of disruption of the normal arrangement of collagen fibrils, but the collagen 
arrangement appeared to be nearly normal after two weeks of injection. These results 
suggested that the injection of glucocorticoids directly into dense fibrous tissue 
weakened the tissue, but the cells can restore toward normal after a single injection. 
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1.4 Platelet-derived Growth Factor Isoform B ( P D G F B B ) 
1.4.1 Structure and Function 
PDGF was originally identified as the most potent mitogen in serum for 
mesenchymally derived cells. Purified human platelet PDGF is a 28-32kDa homo-
and heterodimeric molecule consisting of A (16kD) and B (14kD) chains linked by 
disulfide bonds (Deuel and Huang, 1984; Heldin and Westermark, 1987). A and B 
chains are 40% homologous in sequence and are encoded by distinctly different 
genes. Its activity is mediated by a specific receptor on the cell membrane. This 
receptor is an 18-kD glycoprotein with tyrosine kinase activity. Not all cell type 
expressed PDGF receptors, but only connective tissues such as skin and tendon 
fibroblast, vascular smooth muscle cells, glial cells, and chrondrocytes. Recently, 
Banes has shown that tendon cells responded mitogenically to PDGFBB (Banes et al 
1995). 
PDGF activates two distinct receptors encoded by separate genes. PDGF-AA binds 
only to a-PDGF receptor but PDGF-AB and PDGF-BB bind to both a and p 
receptors. Both a and p receptors have been shown to induce mitogenic signals, but 
only the p receptor is able to mediate stimulation of chemotaxis (Heldin et al 1996). 
PDGF also has been shown to stimulate the production of matrix components by 
fibroblasts, such as fibronectin (Blatti et al 1988) and hyaluronic acid (Heldin et al 
1989)，and it is also able to stimulate the contraction of collagen matrix (Clark et al 
1989). Therefore, PDGFBB was chosen for counteract the deleterious effect of 
dexamethasone. 
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1,4.2 PDGFBB effects on Tendon 
PDGF is a major mitogen for fibroblasts, smooth muscle cells, and other cells. 
Besides, it also involved in wound healing. In vitro studies of fibroblasts showed that 
avian flexor tendon cells required PDGFBB in addition to mechanical load to 
stimulate DNA synthesis (Banes et al 1995). Moreover, it has been reported as a 
potent mitogenic agent in tendon healing and increased fibroblast proliferation (Chan 
PB 1998). A tissue explant study has shown that tendons increase DNA synthesis in 
response to PDGFBB (Abrahamsson et al 1996). 
Moreover, in vivo application of PDGF has been shown to stimulate proliferation of 
mature tendon fibroblasts in a rat-tail tendon model (Stein LE 1985). Another group 
of researchers also found that this growth factor could stimulate DNA synthesis in 
sheep patellar tendon (Spindler et al 1996). Besides, it could specifically modulate 
collagen metabolism by regulating collagenase synthesis (Wilson et al 1993). 
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2.1 Limitation of the Past Researches 
Tendon ruptures after glucocorticoid injection were repeatedly reported over the past 
50 years although the occurrence was not so high. Previous researches tried to assess 
this aspect, but the causal relationship has not been firmly established. The 
inconsistent results were obtained that may be partially due to different experimental 
designs, injection site (direct to tendon or nearby), different dosage and duration of 
glucocorticoid administration. Besides, most previous researches were limited in 
measuring mechanical property of the tendon without revealing other parameters 
such as cell metabolism or collagen and proteoglycan levels. Moreover, in vivo study 
always involves a complex system which cannot clearly shown the direct relationship 
of glucocorticoid administration and tendon rupture. 
Therefore, this study has highlighted this poorly studied area by focusing on the 
effects of glucocorticoid on human tendon fibroblasts using cell culture model. A 
direct intervention could be demonstrated using this system. 
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2.2 Hypothesis of This Study 
From the clinical occurrence of tendon rupture after glucocorticoids administration 
and from the result of the past in vivo studies, we hypothesize that glucocorticoids 
have deleterious effect(s) on tendon fibroblasts. It may have cytotoxic and cytostatic 
effects on the cells, and also affects regulation of matrix syntheses, so ultimately 
weakens the tendon. Besides, we hypothesize that PDGFBB which is a well-known 
mitogen of fibroblasts, can modulate the inhibitory-effects exerted by glucocorticoids. 
And so may provide a protective way to allow the continuous use of this useful 
regime (glucocorticoid). 
Therefore, the effects of glucocorticoid (dexamethasone) on cell cycle, viable cell 
number, cell proliferation, apoptosis, collagen and proteoglycan syntheses of 
fibroblasts isolated from human tendon was investigated in vitro. This study provides 
a direct evidence of glucocorticoid on human tendon fibroblasts in different 
parameters. Results from this study would lead to an important advance in our 
understanding of the development of tendon rupture after glucocorticoid 
administration. And also it is of clinical relevance in deciding future glucocorticoid 
use. 
In the second part of the study, PDGFBB was added together with dexamethasone, 
and same parameters mentioned before were examined. Since PDGFBB is a well-
known mitogenic factor to fibroblasts, therefore, we hypothesis that this growth 
factor may help to protect tendon from rupture after glucocorticoids administration. 
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2.3 Objectives 
The objectives of this study are: 
1. To study in vitro effects of dexamethasone on cellular metabolism and 
matrix syntheses on human tendon fibroblasts. 
2. To investigate the reversibility of the inhibitory effects of dexamethasone by 
PDGFBB. 
2.4 Long Term Significance 
Results form this project will help us to establish a direct cause-effect relationship 
between glucocorticoid administration and tendon disorder. Thereby, it can provide a 
better understanding the underlying mechanism of this clinical phenomenon. 
In the second part of the study, the demonstration of protective effect of PDGFBB on 
glucocorticoid-damaged tendon fibroblasts may provide a solution to reduce tendon 
rupture during glucocorticoid injection in clinical practice. 
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3.1 Chemicals and Materials Used 
3.1.1 Chemicals 
Chp.mical Purchasp.d from 
Bovine serum albumin (BSA) Sigma, St. Louis, MO 
Dexamethasone (Dexa) 
Dulbecco's buffered saline (PBS) 
Dimethyl sulfoxide (DMSO) 
N-[2-hydroxyethyl] piperazine-N'-[2-ethanesulfonic acid] (HEPES) 






Trypan blue crystal (typelll) 
TritionX-100  
Human recombinant platelet-derived growth factor isoform B (PDGFBB) R&D system, Minieapolis, MN 
Proliferation kit (RPN20) using 5-bromo-2'-deoxyuridine (BrdU) Radiochemical Centre, Amersham, UK 
^H-Proline 
35Sulfate  
Hi-Safe scintillant Wallac OY, EG&G Company, England 
Fetal bovine serum (FBS) Gibco, Life Technologies, NY 
Dulbecco's Modification of Eagles Medium (DMEM) 
Phenol red-free DMEM 
Penicillin streptomycin fungizone solution  
Biotinylated human anti-goat PDGFBB receptor Vector Labs, Inc., Burlingame, CA 
Vectastain ABC reagent  
Cell death detection ELISA Plus (1774 425) Roche Molecular Biochemicals, USA 
Dextran T-70 Pharmacia, Peapack, NJ  
3.1.2 Materials 
Matprial Pufcha^itid from 
Plastic culture dish (60mm) Falcon, Lincoln Park, New Jersey 
Plastic culture flask (75mm)  
Culture plates (96-well and 24-well) Coster, Cambridge, MA  
Hemacytometer American Optical, buffalo, NY  
Dialysis Tubing 3787-D22 Arthur H Thomas Co, Philadelphia, USA 
Universal microplate reader ELxSOOUV Bio-Tek Instruments, Inc, USA 
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3.2 Specimen Collection and Preparation 
3,2,1 Collection 
The use of human patellar tendon for study was approved by the Human Ethics 
Committee of the Chinese University of Hong Kong. 25 specimens (18 from men; 7 
from female) were obtained from patients aged between 17 and 50 years undergoing 
anterior cruciate ligament (ACL) reconstruction surgery. In order to have a better 
comparison among the results and the easy in obtaining a patellar tendon biopsy 
rather than other tendon tissue, only patellar tendon was chosen in this study. Tendon 
biopsies (Fig.6) sized 2mm x 2mm x 3cm, were immediately transferred into sterile 
culture medium (DMEM) containing 10% fetal bovine serum (FBS). After operation 
all procedures were conducted inside a sterile biological safety carbinet and tendon 
fibroblasts isolated were cultured within an hour of surgery. 
Hb||BS| 
i II i_ii4iiiiJ 
Figure 6. Human patellar tendon sample. 
Healthy human patellar tendon is brilliant white in color. 
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3,2.2 Preparation of Primary Culture 
Human patellar tendon biopsy was stripped of their paratenon sheath and other 
surrounding substances such as the nearby capillaries or fat. Cell culture method was 
modified from the previous study (Chan et al 1997). Tendon was then washed twice 
with phosphate buffered saline (PBS) containing 1% antibiotic mixture (lOOU/ml 
Penicillin and lOOjig/ml stretomycin) for 3 minutes. The tendon was then minced 
into small pieces of approximately Imm^ each and was digested with 2.5% trypsin 
(w/v) for 5 minutes in order to breakdown the core and link proteins in the tendon 
matrix. Trypsinization was then stopped by adding the DMEM medium containing 
10% FBS. The tissue was subsequently attached onto the plastic culture dish (Fig.7) 
and medium was changed for every 3 days. 
I^ ^^ MKIbCThiiI miuliiiii ff •丨 
Figure 7. Tendon explant culture. 
Tendon was minced into small pieces (Imm^ each) and attached onto culture dish. 
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3,2.3 Isolation the Fibroblast and Cell Culture 
Fibroblasts were released from the explant within 2 weeks (Fig.8). The cells grown 
out of explants were called primary cells and have properties that closely resemble 
fibroblasts in vivo. The released cells were then removed from the culture dish by 
trypsinization (2.5% w/v trypsin, 5 minutes). Followed by centrifugation at 450 x g 
for 5 minutes at room temperature, the cell pellet was then resuspended in 10% FBS 
medium and seeded (5x10^ cells/ml) in 75cm^ plastic tissue culture flask in 10ml of 
DMEM containing 10% FBS. The flask was placed in a high-humidity incubator 
with 5% CO2 / 95% O2 at 37°C. Cells were passed at regular intervals (1 week) to 
maintained at the mid log phase of growth. Medium was changed every 3 days. In 
order to avoid the possibility of dedifferentiation in cell culture system, only cells in 
passages 1-3 were used for the following experiments. 
Figure 8. Fibroblasts released from tendon explant. 
Human patellar tendon fibroblasts migrated from the explant 
and appeared spindle-shape. (Original magnification, 200x) 
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3.3 Reagent Preparation 
3.3.1 Charcoal-stripped Serum 
Hormones present in the commercial supplied serum may mask the effect of 
hormones under examination. Thus, a careful adjustment of medium components not 
only provides an optimal nutrient balance, but also proper experimental condition. 
Since dexamethasone is a kind of glucocorticoid, we should eliminate the effect of 
estradiol or other related factors in our study that may mask the actual effect of 
dexamethasone on tendon fibroblast. The main source of glucocorticoid is that 
presented in the FBS and the phenol in the medium (DMEM). At present, estradiol 
free fetal bovine serum is not available commercially. Therefore, charcoal stripped 
fetal bovine serum was used to minimize the effect of the estradiol. In fact, this 
method cannot totally remove all estradiol in the medium. Small amount of estradiol 
(0.0016ng/ml of estradiol in 10% charcoal stripped FBS) was still present and it has 
been shown to be sufficient to maintain the normal growth of fibroblasts (Nilsson et 
al 1978). 
According to Green, estradiol and its related factors in the serum could be minimized 
by the following method (Green et al 1987). First, a cocktail of a solution comprised 
of 0.25M sucrose/1.5mM MgCyiOmM HEPES at pH7.4 was prepared. Then, 0.25% 
w/v Norit A charcoal and 0.0025% w/v dextran T-70 were added to the cocktail 
solution and placed at 4�C overnight. A volume of the dextran-coated charcoal (DCC) 
equivalent to that of the serum which was to be stripped, was taken and centrifuged 
(2400rpm for lOmin) to pellet the charcoal. Afterwards, the supernatant was 
decanted and the same volume of FBS was placed. This mixture was mixed 
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thoroughly and incubated for 12 hours at 4°C. DCC-stripped serum was filtered by 
0.22jaM Millipore filter to remove the charcoal before use. Phenol-red free DMEM 
containing 10% (v/v) DCC-stripped serum was used in all following experiments. 
3.3.2 Phenol-red Free DMEM 
Since phenol has been shown to have estrogenic properties (Hubert et al 1986), 
therefore, we chose phenol-red free DMEM as a culture medium to eliminate this 
estradiol effect. The DMEM power, together with NazCCh，was dissolved in milli-
distilled H2O and adjusted to pH7.2. The pH value would increase approximately by 
0.1 after filtration. Therefore, the final pH value of the medium should be around 
7.3-7.4，which is the optimal pH for cell growth. 
5.5.5 MTT 
MTT power was dissolved in PBS to final concentration of Img/ml. The dissolved 
solution was then filtered and kept in dark at 4�C. 
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3.3.4 Dexamethasone 
Dexamethasone was dissolved in 10% FBS phenol-red free DMEM to the 
concentration of lOOOjiM and sterilized by filtration through a 0.22jiM millipore 
filter. This solution was kept in dark at 4°C. Drug was then diluted serially to various 
concentrations (0.001 to lOOjiiM) by culture medium before addition to the cells. 
Concentration ranges were selected based on values from the literature with respect 
to use of this drug in vitro and attempting to use concentrations which could be 
achieved in plasma if the drug was used under current prescribing conditions. 
3.3.5 PDGFBB 
Since PDGF tended to adhere nonspecifically to container surfaces, such as the tissue 
culture ware plastic surface. Therefore, it was dissolved to a final concentration of 
10|ag/ml in PBS containing 1% BSA to reduce the nonspecific binding. Growth 
factor would be stored at this concentration at ( C . Further dilution to lOng/ml will 
be performed just before adding this growth factor to the cells. The choice of 
lOng/ml was based on the findings from other literature that PDGFBB usually has 
obvious effect under this concentration. 
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3.3.6 Trypan Blue Solution 
Trypan blue crystal was dissolved in PBS at a concentration of 0.1% (w/v). The 
solution was stored at 4®C after filtration. 
3.3.7 TCA/Tannic Acid 
Two different concentrations of TCA/Tannic acid were needed for the ^H-proline 
incorporation assay. 10% TCA/0.5% tannic acid was prepared by dissolving lOg 
trichloroacetic acid (TCA) and 0.5g tannic acid into 100ml distilled water. 5% 
TCA/0.25% tannic acid was obtained by diluting the 10% TCA/0.5% tannic acid 
with equal volume of distilled water. 
3.3.8 Collagenase Buffer 
6.057g Tris, 14.702g CaCl2.2H20 and 0.313g N-ethylmaleimide were dissolved in 
90ml distilled water. The solution was titrated with HCl to pH 7.4 at room 
temperature and diluted to 100ml with distilled water. 
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3.4 Morphology 
3.4.1 Inverted Phase Contrast Light Microscopy 
After treated with culture medium D M E M , dexamethasone or PDGFBB, gross cell 
morphology of fibroblasts was observed under the conventional inverted phase 
contrast light microscope (Nikon ECLIPSE TE300, Tokyo, Japan). Collagen fibril 
exocytosized outside the cells was examined by the scanning electron microscope 
(SEM). 
3.4.2 Scanning Electron Microscopy (SEM) 
Since biochemical and ultrastructural studies suggested that polymerization occurred 
inside the fibroblast, with collagen fibrils being released by exocytosis outside the 
cells (Bomstein P 1980), SEM was used to examine the collagen fibrils secreted 
from the tendon fibroblasts. Cells were cultured on 0.1% gelatine-coated glass cover 
slides for at least 24 hours for attachment. Then, cells were treated with 
dexamethasone or PDGF for 2 days. The adherent cells were washed twice with pre-
warmed PBS buffer and fixed with 2.5% glutaraldehyde in O.IM cacodylate buffer at 
pH7.4. Glutaraldehyde helps to preserve the native structures in collagenous tissues 
and eliminates limpness by displacing the water. After dehydration in ethanol 
solution, samples were then sputter-coated with gold palladium using a sputter coater 
for 1 minute to enhance surface detail. Collagen fibrils secreted from the cells were 
then analyzed using a scanning electron microscope (JSM 6301F). 
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Collagen fibrils could be identify under scanning electron microscope because they 
display a very marked constant periodicity of about 67nm leading to a banded or 
striated appearance along their length. 
Figure 9. Collagen fibrils “shadowed，，with heavy metal atoms to show the 
periodic structure. (Woodhead-Galloway J 1980). 
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3.5 Biological Assay 
3.5,1 MTT (3-[4，5-Dimethylthiazol-2-yl]2，5-(liphenyltetrazolium bromide) Assay 
MTT assay (Mosmann T 1983) is an indirect measure of the number of viable cells. 
It is based on the measurement of the mitochrondrial enzyme activity (NAD-
dependent dehydrogenase), and the overall metabolic activity in a cell population can 
be determined. The assay utilizes a tetrazolium salt MTT, which is reduced by NAD-
dependent dehydrogenase (mitochrodrial enzyme succinate dehydrogenase) activity 
inside cells to form a colored reaction product (formazan). After dissolution of the 
blue crystalline product, the color can be measured by spectrophotometer at 570 nm. 
3.5.1,1 Correlation between MTT assay and Trypan Blue Dye Method 
In MTT assay, it was assuming that the mitochrondrial enzymatic activity was equal 
in each cell and the tested substance (e.g. dexamethasone) would not affect this 
enzymatic activity. However, in some conditions，this assay cannot truly reflect the 
cell viability directly. For instance, when the drug directly affects the mitochondria 
metabolism. Therefore, before examining the cytotoxic effect of dexamethasone on 
the tendon fibroblast using MTT assay, it was necessary to correlate the MTT results 
with the cell counts measured by trypan blue exclusion assay. The trypan blue 
exclusion assay was based on the principle that viable cells can actively exclude the 
toxic trypan blue dye (0.2%) entering the cells. Thus, it was used as a direct measure 
of viable cell number. 
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Fibroblasts were seeded at density 5xl0^cell/well to the 96-well culture plate in 
triplicate for 24 hours to facilitate cell attachment. Afterwards, cell number was 
determined by trypan blue dye exclusion assay and MTT method. For the trypan blue 
dye exclusion assay, a cell suspension was prepared by trypsinization, centrifugation, 
and resuspension of the fibroblasts in DMEM. 10|li1 of the fibroblast suspension was 
mixed with equal amount of trypan blue stain and the percentage of viable cells was 
determined by direct cell counting under a microscope. 
For the MTT assay, 50jil/well MTT solution was added to each well and incubated 
for 4 hours at 37°C. Afterwards, 150jal/well DMSO was added to dissolve the cell 
and released the color substances and the optical density was measured at 570nm. 
The two sets of data were plotted together with direct cell number counted from the 
trypan blue dye method as X-axis; while the optical density (OD) obtained form the 
MTT assay as Y-axis. As shown from the graph (Fig. 10)，the correlation (R^) of 
values measured by these two methods were 0.9624, showing a valid conversion. 
Therefore, MTT assay could be used to determine the cell number directly. 
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Figure 10. Correlation between the MTT assay and trypan blue dye exclusion 
assay. 
Y-axis represents the optical density (OD570) measured from the MTT assay, while 
the X-axis represents the cell number determined by the trypan blue dye exclusion 
test. It showed a high correlation (r2= 0.9624). Results were presented as means 士 
S.D of three determinations. 
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3.5,1,2 Growth Kinetics of Tendon Fibroblasts 
Normally, fibroblasts grow continuously until confluent, after which they will cease 
to growth due to cell-cell contact inhibition. The cells the start to differentiate, 
synthesize and deposit extracellular matrix. Therefore, selection of a suitable assay 
time is important. For instance, contact inhibition may mask the effect of substance 
on cell proliferation, leading to under-estimation resulted. On the other hand, assay 
time should be chosen after cell proliferation when we examine the effect of a 
substance on the extracellular matrix metabolism. Therefore, the growth kinetics for 
tendon fibroblasts was determined prior to other biological assays. 
In order to construct the growth kinetics for human tendon fibroblast, MTT assay 
was performed. Isolated fibroblasts were plated on 96-well tissue plates at a density 
of 5x10^ cells per well for 24 hours. After attachment to the bottom of the well, 
fibroblasts were cultured with medium consisting 10% FBS, IjuM dexamethasone or 
lOng/ml PDGFBB. The number of viable cell was measured on Day 0, 2, 4，6 and 8. 
Culture medium was refreshed every 2 days. From Figurell, fibroblast grew 
continuously from day 0 to day 4 under three different culture conditions, therefore, 
days 1-4 were suitable for cell viability and proliferation detection. In contrast, no 
significantly increased in cell viability indicating inactive cell division after Day 6. 
Thus this was a suitable time for matrix examination. 
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Figure 11. Growth kinetics of human tendon fibroblast under different culture 
conditions. 
Growth kinetics of human tendon fibroblasts was determined by the MTT assay. 
Fibroblasts cultured in medium DMEM with 10% serum have a constant growth in 
the first 6 days and became plateau afterwards. In the presence of dexamethasone, 
cell growth was retarded when compared to the control group. In contrast, PDGFBB 
stimulated the cell growth rapidly and reached the confluent level earlier on Day4. 
Results were presented as means 士 S.D of three determinations. 
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3.5,1.3 Cell Viability 
Cell viability was assessed using the MTT techniques, human tendon fibroblasts 
were plated at 5x10^ cells/well using 96-well tissue culture plates for 24 hours to 
allow cell attachment to the bottom of the wells. Fibroblasts were then divided into 4 
groups and cultured in (a) complete medium, (b) various concentrations of 
dexamethasone (0.001，0.01’ 0.1，1, 10, lOOjiiM), (c) lOng/ml PDGFBB and (d) 
dexamethasone plus PDGFBB. This day was assigned as Day 0. Cells were incubated 
in 37�C for 4 days with medium, dexamethasone or PDGF, refreshed once on Day 2. 
On Day 4, culture medium was aspirated and washed once with PBS. SOjul MTT 
solution (Img/ml) was added to each well for 4 hours at 37°C. The colored reaction 
product (formazan) was then dissolved with 150|al DMSO. Optical density (OD) was 
measured at 570nm by a ELISA plate reader (ELxSOOUV, Bio-tek Instrument Inc). 
The effect of dexamethasone on viable cell number has also been detected in rat 
patellar tendon. All the experimental procedures were the same as that of the human, 
only shortened the incubation and assay time point (from Day4 to Day2) because 
cells derived from rat grew more rapidly than those derived form human tissue. 
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3.5.2 BrdU (5-bromo-2 '-deoxyuridine) Assay 
Cell proliferation was traditionally measured by the [^H]-thymidine incorporation. 
However, the use of this radioactive substance is the disadvantage of this assay. 
Therefore, a non-radioactive pyrimidine analogue (BrdU) was used to measure cell 
proliferation (Huong et al 1991). The principle of the assay is that replicating cells 
will uptake BrdU for new DNA synthesis. Thereby, the amount of this analogue 
incorporated into the cell reflected the cell proliferation. 
Tendon fibroblasts were cultured with (a) DMEM, (b) various concentrations of 
dexamethasone, (c) PDGFBB lOng/ml and (d) dexmethasone plus PDGFBB for 4 days. 
Afterwards, DNA synthesis in fibroblasts was measured using the BrdU-labeling and 
detection kit (BrdU-Kit III, Boehringer Mannheim). lOjul BrdU (lOj^M) was added to 
the cells without removing the culture medium. During this labeling period, BrdU 
was incorporated in place of thymidine into the DNA of proliferating cells. After 4-
hour incubation, cells were fixed for 30 minutes using fixing solution provided with 
the kit. Thereafter, anti-BrdU-peroxidase was added to each well to bind to the BrdU 
in the DNA for 90 minutes, the un-bound one was removed by washing the wells 
three times with wash solution. After removing the wash solution, lOOj^l/well 
substrate solution (tetramethylbenzidine) was added and incubated for 15 minutes for 
color development and the optical density was measured by an ELISA reader at 
340nm with reference wavelength 490nm. 
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3.5.3 Flow Cytometry 
The number of DNA strand of the cell is changing during different phase of cell 
cycle. For instance, cell has a copy of DNA in the GO/Gl phase. When the cell enters 
S phase, it starts to replicate its DNA and has two copies of DNA in the G2/M phase. 
Therefore, DNA dye which stains DNA strands can be used for determining the stage 
of cell cycle. The higher the DNA content, the higher the fluorescence intensity. In 
this study, cell cycle was analyzed using a common DNA dye ——propidium iodide 
(PI). This dye can intercalate in the DNA helix and fluorescence red strongly. 
Before assay, 1x10^ fibroblasts were seeded into a 25cm^ flask for 24 hours. 
Afterwards, cells were cultured in (a) DMEM with 10% FBS, (b) IjiiM 
dexamethasone, (c) lOng/ml PDGFBB or (d) dexamethasone + lOng/ml 
PDGFBB. After 4 days, the cells were then removed from the flasks by trypsinization 
and suspended in the 70% alcohol for 15 minutes. Ethanol-fixed cells were 
permeabilized using 1ml tritionX-100 (0.1%) in PBS for 10 minutes at room 
temperature. Since PI can also stain double-stranded RNA, therefore, these RNA 
strands should be removed by the ribonuclease. So, RNA strands were then digested 
using 20|al ribonuclease A (lOmg/ml) for 10 minutes at 37°C. Follow then, the DNA 
strands were stained with 20[i\ PI (Img/ml) for 30 minutes at room temperature. The 
stained cells were analysed using a Coulter ®EPICS ALTRA flow cytometer 
(Beckman Coulter) equipped with an air-cooled Argon-Laser (15mW). PI 
fluorescence was measured through the 675nm band-pass filter. 
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The discrimination between G1 doublets and G2 cells was achieved by correlated 
measurements of pulse area and peak of red fluorescence signal. For each sample, 
3x104 cells were analyzed. The percentages of cells in different phases were 
calculated by the "ModFit LT cell cycle modeling" software. This method can also 
be used to detect apoptosis nuclei based on the presence of subdiploid DNA peak in 
the DNA fluorescence histogram. 
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3,5,4 Apoptosis 
Apoptosis is the biological process by which cells in tissues undergo programmed 
cell death. Fragmented DNA is often regarded as the hallmark of apoptosis (Wyllie et 
al 1984). Thus, the enrichment of mono- and oligonucleosomes in the cytoplasm of 
the cells can be used for the detection of apoptosis. 
Fibroblasts were treated with either DMEM or IjuM dexamethasone for 4 days. 
Apoptosis was then detected by using an apoptosis detection kit (Cell Death 
Detection ELISA Plus, Roche). Cells were lysed with lysis buffer provided from the 
kit and then centrifuged at 200xg for 10 minutes. 20|LI1 supernatant (cytoplasmic 
fraction) was added into streptavidin-coated plate. A mixture of anti-histone-biotin 
and anti-DNA-POD were added and incubated together for 2 hours at room 
temperature. During the incubation period, the anti-histone antibody binded to the 
histone-component of the nucleosomes and simultaneously captured the 
immunocomplex to the streptavidin-coated plate via its biotinylation. In addition, the 
anti-DNA-POD antibody reacted with the DNA-component of the nucleosomes. 
After incubation, unbound components were removed and the amount of 
nucleosomes was detected photometrically by adding lOOjul/well of 2,2'-azino-di-[3-
ethylbeIlzthiazoline sulfonate] (ABTS) solution. The color development was 
measured at 405nm with reference wavelength 490nm. The higher the color intensity, 
the more abundant the apoptotic cells. 
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3,5.5 ^H'Proline Incorporation Assay 
Collagen is synthesized initially as a precursor molecule designated procollagen. The 
synthesis and secretion of collagen requires hydroxylation of proline and lysine 
residues (Table. 1). This is also the rate-limiting step in the biosynthetic pathway of 
the collagen fiber. The incorporation of^H-proline into collagenase-digestible protein 
(CDP) was determined using highly purified bacterial collagenase by the method of 
Peterkofsky and Diegelmann (1971). 
Step Organelles, Process And Cofactors  
1. Transcription Nucleus 
2. Translation of mRNA Membrane-bound ribosomes 
Cleavage of hydrophobic leader sequence 
3. Completion of proa chain synthesis Peptidyl hydroxylation 
Glycosylation 
4. Chain assembly and folding Bisulphide bond and triple helix formation 
5. Intracellular translocation and secretion Additional glycosylation in Golgi complex 
Exocytosis of GolgiOderived vesicles 
6. Conversion of procollagen to collagen Limited proteolysis by NH2- and COOH-terminal 
procollagen proteases 
Molecular assembly 
7. Fibre and cross-link formation Oxidative deamination by lysyl oxidase 
Formation of lysyl and hydroxylysyl-derived cross- 
links  
Table 1. Pathway of collagen biosynthesis (Hay ED 1991). 
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Figure 12. The intra- and extracellular phases of collagen biosynthesis 
(Woodhead-Galloway J 1980). 
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Isolated fibroblasts were seeded into 24-well culture plate at a density of 2x1 O^  
cell/well for 6 days. Confluent monolayer cultures obtained at Day 6 were treated 
with: (a) complete medium DMEM, (b) IjiiM dexamethasone, (c) lOng/ml PDGFBB 
or (d) 1|LIM dexamethasone plus lOng/ml PDGFBB for 48 hours. During the last 24-
hour，cells were pulsed with lOjuCi per well ^H-proline at 37�C. Culture medium was 
then removed and the well was rinsed with PBS twice. Fibroblasts were then lyzed 
by the addition of 1ml O.IN NaOH. This homogenate was transferred to 2ml ice-cold 
10% TCA/0.5% tannic acid. The well was rinsed with another 1ml O.IN NaOH and 
pooled to the same solution. The mixture was left at O^ 'C for 5 minutes, and 
afterwards, it was centrifuged at 29,000xg for 10 minutes. Supernatant was then 
discarded and the pellet was washed with 0.5% TCA/0.25% tannic acid. Mixture was 
centrifuged once again as before. Pellet obtained after centrifugation was dissolved 
in 1ml O.IN NaOH by warming at 3TC water bath. 0.2 ml 0.09N HCl was added for 
neutralization. 50|il collagenase buffer were added together with 50|il collagenase or 
water as collagenase-free control. The solution was then mixed well and 
incubated at 37�C shaking bath for 3 hours. 
Collagenase digestion was stopped by adding 0.5ml ice-cold 10% TCA/0.5% tannic 
acid in ice bath for 5 minutes. The cells were then treated with ice-cold 10% 
trichloroacetic acid to remove the unincorporated nucleotide. The mixture was then 
centrifuged at 9,000xg for lOminutes. 0.5ml supernatant was taken and mixed well 
with 4ml liquid scintillant. Amount of collagen synthesized was calculated by the 
difference between the count per minute (cpm) measured in the presence and the 
absence of collagenase (background). Final results were obtained after normalize the 
cell number in each group. 
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3,5.6 3sSulfate Incorporation Assay 
In vitro, radiolabeling provides the most convenient way to follow proteoglycan 
* 35 
synthesis. Sulfate is usually used to label proteoglycans selectively, because more 
than 90% of the incorporated activity with this precursor will be in proteoglycan 
(Yanagishita et al 1987). Besides, tendon tissue mainly synthesizes dermatan sulfate 
(proteoglycan), which also contains high proportion of sulfate. Therefore, this 
method was used to assess the proteoglycan synthesis of tendon fibroblast. 
The biosynthesis of proteoglycan involves the formation of repeating disaccharide 
chains linked to a core protein. Labeled sulfate is directly converted to adenosine 3，-
phosphate 5'-P-dihydrogen phosphatosulphate (PAPS) without significant dilution 
from metabolic sources of sulfate (Fig. 13). PAPS then entered to Golgi 
compartments and combined together with the N-acetylgalactosamine (GalNAc) and 
glucuronic acid (GlcA), to form dermatan sulfate (DS). 
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Figure 13. The biosynthetic pathway of proteoglycan (lozzo RV 2000). 
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Proteoglycan synthesis was measured by the ^^sulfate-incorporation method (Lee et 
al 1996). Tendon fibroblasts were seeded at 20,000 cell/well in 24-well culture plate 
for 24 hours. Then the medium was refreshed and this day was assigned as Day 0. 
Cells were allowed to grow at confluent level for 6 days. At day 6, 1ml of 
dexamethasone (l\xM), PDGFBB(10ng/ml), or DMEM were added to the cells and 
further incubated for 48 hours. At the last 24-hour of the incubation time, 10|aCi/well 
35-sulphur was added. After incubation, the medium was removed and 0.5ml/well 
0.25N NaOH was added to each wells until the cells were dissolved to liberate the 
newly-synthesized ^^[S]04-labeled macromolecules (proteoglycan). The solution was 
then transferred to new plastic tubes, and each well was rinsed with another 0.5ml 
0.25N NaOH. The solution was then transferred to the corresponding tubes as well. 
1.5ml 0.25N NaCl was added to each tube to balance the salt with PBS. Then the 
mixtures were dialyzed in PBS using dialysis tubing. This step allowed the removal 
of unincorporated sulfate. PBS was changed for totally 5 times with each time at 
least 5 hours apart. The solution was then transferred to new plastic tubes and 2.5ml 
solution from each tube was transferred into 20ml plastic scintillation vials. And 
17.5ml scintillant (Hi-Safe 2) was added to each vial and mixed thoroughly. The 
radioactivity was counted by liquid scintillation counter (Packard Instrument 
Company). Since, sugar precursors will also form covalent bonds with amino groups 
in proteins by nonenzymatic glycation (Bernstein RE 1987)，a particular problem if 
serum is present in the labeling medium (Yanagishita M 1987). Therefore, control 
cultures without cells can be used to estimate the contribution of this process to the 
macromolecular radioactivity. Cell numbers were counted by using hemocytometer. 
And the radioactivity was divided by the corresponding cell number. 
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3,5.7Immunocytochemistry (PDGF-r协 
Cultured tendon fibroblasts were seeded in 96-well culture plates and grown at 3TC 
in complete medium for 24 hours. Afterwards, culture medium was refreshed with (a) 
complete medium, (b) IJUM dexamethasone, (c) lOng/ml PDGFBB and (d) Ij^M plus 
lOng/ML PDGFBB. Cells were kept for 4 days with medium changed once at day 2. 
Then, cells were fixed in 4% paraformaldehyde for 10 minutes, and the endogenous 
peroxidase was quenched in 0.5% H2O2 twice, 10 minutes each time. Non-specific 
binding sites were blocked by 1% BSA in PBS for 30 minutes at room temperature. 
After washing for three times in PBS, the cells were then exposed to the primary 
antibody anti-human PDGFBB receptor (1:500 in 1% BSA) at 4 � C overnight and 
washed for 4 times in PBS with 3-minute each wash. Then, the antibody complexes 
were incubated with biotinylated IgG directed against the secondary antibody for 30 
minutes. Positive signals were obtained after addition of ABC-alkaline phosphatase 
substrate (Vector Labs, Inc.) for 1 hour at room temperature. Cells were 
counterstained with haematoxyline. As a negative control, bovine serum albumin 
was used instead of the anti-human PDGFBB receptor. Histological signaling was 
detected by image analysis. 
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3.6 Statistical Analysis 
3.6.1 Dose-response curve of dexamethasone on cell viability and proliferation 
Results from the MTT and BrdU assays were compared with one-way analysis of 
variance (ANOVA) test among various dosage of dexamethasone. P-value smaller 
than 0.05 regarded as statistically significant. 
Comparison among various treatments of fibroblasts 
In MTT assay, BrdU assay, ^H-proline incorporation assay and ^^Sulfate 
incorporation assay, One-sample t test was performed for the following comparison: 
(a) control and dexamethasone-treated group; (b) control and PDGpBB-treated; and (c) 
control and co-incubation group. For the comparison between the dexamethasone-
treated and co-incubation group, paired t test was performed. 
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4.1 In Vitro Effect of Dexamethasone on Rat Tendon Fibroblasts 
4.1,1 Viable cell number between two sexes 
From the result of the MTT assay, there was a dose-response decrease in viable cell 
number in the presence of dexamethasone. When rat tendon fibroblasts were cultured 
with dexamethasone, cell viability of fibroblasts isolated from male rat was similar to 
those isolated from female. No significant difference between two sexes in response 
to dexamethasone (n=9). 
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Figure 14. E r ror bar plot showing the effect of dexamethasone on cell viability 
between male and female rat tendon fibroblasts. 
Re�:ults were expressed as means with 9 5 % CI of nine de termina t ions No significant 
difference be tween two sexes in response to dexamethasone at each concentrat ion 
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4.2 In Vitro Effects of Dexamethasone and P D G F B B on human tendon fibroblasts 
4,2,1 Gross Morphology 
Tendon fibroblasts cultured in the complete medium have typically spindle-shaped 
morphology when examined under inverted phase contrast light microscopy. They 
had long processes and flat with a highly attenuated cytoplasm. These processes 
aided its mobility and guide fibroblast over or under a nearby fibroblast (Fig. 15a). 
In the presence of dexamethasone, cells became flattened, with a rounded appearance 
and diminished intercellular contacts (Fig. 15b). In contrast, fibroblasts grown in 
PDGFBB-supplemented medium appeared to develop more spindly appearance 
characterized by branching processes and compact cell body (Fig. 15c). When co-
cultured the fibroblasts with dexamethasone and P D G F B B , cell numbers increased 
greatly when compared to the dexamethasone-treated group, and the cellular 
morphology appeared similar to that of the control group (Fig.l5d). 
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Figure 15. Phase contrast microphotography of tendon fibroblasts after 4-day 
treatment with: (a) DMEM; (b) Dexamethasone; (c) P D G F B B and (d) 
Dexamethasone plus P D G F B B . (Original magnification, 200x). 
Tendon fibroblasts were cultured with: 
(a) DMEM containing 10% FBS. They have bipolar, spindle-shape and long possess; 
(b) Dexamethasone (l|aM). Cells were flatten and polygonal in shape; 
(c) PDGFBB (lOng/ml). Fibroblasts had more spindle-appearance and branching 
processes. 
(d) Dexamethasone (l^iM) + PDGFBB (lOng/ml). Cell morphology appeared similar 
to that of the control group. 
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4.Z2 Cell Cycle 
Table 2 showed the representative result in flow cytometric analysis of human tendon 
fibroblasts cultured with D M E M , dexamethasone or PDGFBB for 4 days. Cell cycle 
and apoptosis were evaluated by PI staining of DNA content. Results showed that 
dexamethasone inhibited cell proliferation as shown in the decreased percentage of 
cells in DNA synthesis phase (S phase). On the other hand, PDGFBB promoted more 
cells to proliferate when compared to the control group (13% verses 6%). When co-
cultured the fibroblasts with dexamethasone and PDGFBB, dexamethasone-inhibited 
proliferation was overcome by the presence of PDGFBB. Neither dexamethasone nor 
PDGFBB would induce apoptosis of tendon fibroblasts. 
^ ^ ^ ^ (%) T ^ A T M E N T 
Cell cycle PIIASE--^ Control Dexa luM PDGFBB lOng/ml Dexa + PDGFBB 
GO/Gl 82.9 90.4 75.1 80.2 
S 5.9 13.3 7.1 
G2+M 11.3 7.6 11.5 12.7 
Apoptosis undetectable undetectable undetectable undetectable 
GO = resting phase 
G1 = gap 1 phase 
S = DNA synthesis phase 
G2 = gap 2 phase 
M = mitotic phase 
Table 2. Representative experiment of the effect of dexamethasone and PDGFBB 
on cell cycle. 
Fibroblasts were cultured in medium supplement with 10% FBS with or without 
dexamethasone (IFAM) or PDGFBB (lOng/ml) for 4 days. The percentage of cell in 
each phase of cell cycle after treatment was determined by the analysis of Pl-stained 
cells on a FACScan. Data was representative of one of six different subjects. In all 
groups, no detectable apoptosis was found. 
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4,2.3 Apoptosis 
There was no apparent apoptosis in human tendon fibroblasts treated with either 
culture medium (DMEM) or IfiM dexamethasone (Fig. 16). And there was 
statistically significant difference between positive control group and the control 
group or between positive control group and dexamethasone-treated group 
(p<0.05,n=9). 
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Figure 16. Bar chart showing apoptosis detection. 
No apoptosis was detected when human tendon fibroblasts were cultured with in 
plain DMEM or dexamethasone (l[iM) for 4 days�Results were expressed as means 
士 S.D. of nine determinations. 
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4,2.4 Cell Viability 
4.2.4.1 Effect of dexamethasone 
When human tendon fibroblasts were cultured with dexamethasone, the viable cell 
number decreased significantly (p<0.001,n=10) (Fig. 17). This dose-response 
decrease of viable cell number became less apparent when the concentration of 
dexamethasone was greater than l\iM. 
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Figure 17. Error bar plot showing the effect of dexamethasone on the cell 
viability of human tendon fibroblasts. 
Human tendon fibroblasts were incubated with various concentrations of 
dexamethasone (0.001-100)iM) at 37�C for 4 days. Cell viability was determined by 
the MTT assay. Symbols represent the mean with 95% CI of triplicate determinations 
from 10 different subjects. One-way ANOVA showed a significant difference 
between control group (absence of dexamethasone) and all concentrations of 
dexamethasone-treated groups (p<0.001, n=10). 
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4.2.4.2 Effect of PDGFBB 
In contrast to the effect of dexamethasone, PDGFBB at the concentration of lOng/ml， 
markedly stimulated the percentage of viable cell number to 164 士 40o/o when 
compared to the control group (p=0.001, n=10). Tendon fibroblasts co-cultured with 
dexamethasone ( 1 _ and PDGFBB have percentage of viable cell number restored 
(92 土 17o/o) similar to the control group. Therefore, the inhibitory effect of 
dexamethasone on viable cell number could be overcome by the presence of PDGFBB. 
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Figure 18. Error bar plot showing the effect of dexamethasone and PDGFBB on 
cell viability of human tendon fibroblasts as measured by the MTT assay. 
Exponentially growing human tendon fibroblasts cultured in (a) DMEM; (b) IjuM 
dexamethasone; (c) lOng/ml PDGFBB or (d) 1|LIM dexamethasone plus lOng/ml 
PDGFBB. The viable cell number was determined by the MTT assay. One-sample t 
test showed a significant difference between the control verses dexamethasone-
treated group (p<0.001, n二 10); and the control verses PDGFeB-treated group 
(p=0.001, n=10). No significant difference was detected between the control group 
and the co-incubation group (dexamethasone plus PDGFBB). Paired t test showed 
statistical significant between dexamethasone-treated group and co-incubation group 
(p<0.001, n=10). P 
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4,2,5 Cell Proliferation 
4/2.5.1 Effect of dexamethasone 
Figure 19 showed the result of BrdU incorporation assay. There was a decreasing 
trend in the proliferation of human patellar tendon fibroblasts with increasing 
dexamethasone concentrations in a dose-response manner. A linear regression model 
showed a significant decreasing slope in all subjects tested (p=0.0063, R^=80.3%, 
n=10). 
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Figure 19. Effect of dexamethasone on BrdU incorporation among 10 subjects. 
Tendon fibroblasts were cultured with various concentrations of dexamethasone 
(0.001-100|iM) for 4 days. Percentage of BrdU incorporation was normalized in each 
concentration group to the control group (without dexamethasone). A linear 
regression model showed a decreasing trend from the pool of 10 cases 
(P=0.0063’R2=80.3%, n=10). 
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When comparing the effect among various concentration of dexamethasone, one-way 
ANOVA was performed and a statistical significance was shown when 
dexamethasone concentration greater than or equal to lOjiiM (p < 0.001, n = 10). 
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Figure 20. Error bar plot showing the effect of dexamethasone on BrdU 
incorporation of human tendon fibroblasts. 
Fibroblasts cultures treated with various dosages of dexamethasone (0.001-100|LIM) 
were pulsed with BrdU for 4 hours. Afterwards, BrdU incorporated in proliferating 
cells was determined as described 'm Materials and Methods. Results were triplicated 
in 10 different subjects. One-way ANOVA showed a significant difference between 
the control group (without dexamethasone) and dexamethasone-treated groups only 
when the concentration greater than or equal to lOjiM (p<0.001,n-10). 
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4,2.5.2 Effect of PDGFBB 
During the 4-hour incorporation period, the amount of BrdU incorporated into the 
proliferating cells was lower in dexamethasone-treated group but higher in PDGFBB-
treated group when compared to the control group (Fig.21). Moreover, the BrdU 
incorporation was restored by lOng/ml PDGFBB in the presence of l|iM 
dexamethasone (co-incubation group). 
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Figure 21. Error bar plot showing the effect of dexamethasone and PDGFBB on 
cell proliferation of human tendon fibroblasts. 
Cells were cultured in DMEM, dexamethasone (l|iM), PDGFBB (lOng/ml), or 
mixture of dexamethasone plus PDGFBB for 4 days. Medium was refreshed once on 
Day 2. Data were presented as means with 95% CI of 10 subjects. One-sample t test 
showed a significant difference between the control verses dexamethasone-treated 
group (p=0.001, n=10); the control verses the POGFeB-treated group (p=0.002, 
n=10). No significant showed between control and co-incubation group. Paired t test 
between dexamethasone-treated and co-incubation group showed significant 
difference (p=0.006, n-10). 
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4.2.6 Collagen Synthesis 
Fibroblasts are secretory cells which release collagen from the cell surface into the 
extracellular matrix. Analysis from the scanning electron microscopy has shown the 
presence of collagen fibril synthesized in each group of treatment. 
From the photo, it was shown that fibroblasts cultured in the culture medium 
(DMEM) have some of collagen fibrils with periodical striation leaving from the cell. 
In the presence of dexamethasone (IjuM), fibroblasts still secreted collagen fibrils but 
appeared longer and finer. On the other hand, cells treated with PDGFBB (lOng/ml) 
alone, have bundles of collagen fibrils with larger diameter. If dexamethasone and 
PDGFBB were co-cultured with tendon fibroblasts, collagen fibrils became thicker 
than those in the dexamethasone-treated group. 
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(a) DMEM (b) Dexamethasone 1 ^ M 
mm 
(c) PDGFBB lOng/ml (d) Dexamethasone IFIM + PDGFBB lOng/ml 
Figure 21. Electron micrograph of human tendon fibroblasts showing the 
collagen fibrils secreted after different treatments. (Original magnification 
20000X, bar 1 micro m). 
(a) DMEM: some of collagen fibrils with periodical striation leaving the cell; 
(b) Dexamethasone IjiM: longer and finer collagen fibrils were secreted; 
(c) PDGFBB lOng/ml: bundles of collagen fibrils with larger diameter been found; 
(d) Dexamethasone IJAM + PDGFBB lOng/ml: collagen fibrils were thicker than 
dexamethasone-treated group. 
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Collagen synthesis was also assessed by radioactive ^H-proline incorporation method. 
Radioactivity counted in each group was standardized with the corresponding cell 
number. And the percentage of collagen synthesis was compared after normalized 
the radioactivity in each group against the control group (DMEM). 
From the result, there was a statistically significant decrease in collagen synthesis in 
dexamethasone-treated group was observed as analyzed by one sample t test 
(p<0.001, n=8). When compare the control group with the PDGFBB-仕eated group, 
PDGFBB stimulated collagen synthesis by 132% statistically significant (p二0.031， 
n=8). On the other hand, collagen synthesis was significantly increased in co-
incubation group when compared to the dexamethasone-treated group (p=0.006, 
n=8). 
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Figure 22. Effect of dexamethasone and PDGFBB on collagen synthesis of human 
tendon fibroblasts. 
Confluent monolayer of fibroblasts was cultured for 2 days with dexamethasone 
(IJIM), PDGFBB (lOng/ml) or mixture of dexamethasone plus PDGFBB- Collagen 
synthesis was then detected by pulsing the cells with ^H-proline at the last 24-hour 
culture time. Data were standardized with the corresponding cell number in each 
group. Results were expressed as the percentage of ^H-proline incorporated in each 
group against the control group. One-sample t test showed a significant difference 
between the control verses dexamethasone-treated group (p<0.001, n=8) and control 
verses PDOFeB-treated group (p=0.031, n=8). Paired-samples t test also showed 
significant difference between dexamethasone-treated and co-incubation group 
(p=0.006, n=8). 
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4,2,7 Proteoglycan Synthesis 
Fibroblast was cultured with dexamethasone for 48 hours and the proteoglycan 
synthesis was measured by the ^^S-incorporation assay. In fibroblasts culture, the 
35 
radioactive S is mainly incorporated into the glycosaminoglycan chains of 
proteoglycan. Results were compared in percentage after standardized of cell number 
and normalized to the control group. 
Fibroblasts cultured with dexamethasone (IjiiM) synthesized 30% less proteoglycan 
as reflected by lower sulfate incorporated into the cultures when compared to the 
control group (p=0.001,n=10) (Fig.23). In contrast, PDGFBB (lOng/ml) could 
significantly stimulated 40% of proteoglycan synthesis when compared to the control 
group (p=0.001，n=10). Moreover, PDGFBB at this concentration could counteract the 
inhibitory effect of dexamethasone and restore the proteoglycan synthesis level near 
to that level of the control group. 
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Figure 23. Effect of dexamethasone and P D G F B B on the proteoglycan synthesis 
of human tendon fibroblast. 
^^S-sulfate incorporation was measured in triplicated cultures of 10 subjects and was 
corrected for the corresponding cell number. Results were expressed as the 
percentage change of ^^S-sulfate incorporated in each group against the control 
group. One-sample student's t test showed a significant difference between control 
and dexamethasone-treated groups (p=0.001,n=10); between control (DMEM) and 
PDGF-treated group (p=0.001,n=10); while no significant was detected between 
control (DMEM) and co-incubation group (dexamethsone plus PDGF). Paired t test 
showed significant difference between dexamethasone-treated and co-incubation 
group (p<0.001,n=10). 
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4.2.8 PDGF-J3receptor expression 
Tendon cells were stained positively with PDGF-P receptor in all groups. In tendon 
cultured with dexamethasone (IJIM), slight staining of PDGF-P receptor was noted 
(Fig.24b). On the other hand, a strong staining was observed in PDGF-treated group 
(Fig.24c). When the fibroblasts were cultured in the mixture of dexamethasone and 
PDGFBB, the signal increased when compared to the dexamethasone-treated group. 
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Figure 24. Effect of dexamethasone and PDGFBB on PDGF-P receptor 
expression. (Original magnification, 200x). 
Fibroblasts were cultured in (a) culture medium DMEM; (b) dexamethasone; 
(c) lOng/ml PDGFBB； and (d) 1|LIM plus lOng/ml PDGFBBB for 4 days. Cells were 
then fixed and immuno-stained with PDGF-p receptor. 
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Local glucocorticoid injection is widely accepted for the treatment of inflammatory 
diseases in soft tissue such as tendon. Although this provides immediately symptom 
relief, local complications such as tendon weakening or ultimately tendon rupture 
were reported (Chechick et al 1982; Clark et al 1995; Karpman et al 1980; Kleinman 
et al 1983; Melmed EP 1965; Newnham et al 1991; Smaill GB 1961; Smith et al 
1999; Stannard et al 1993). Indeed, the incidence rate of glucocorticoid-induced 
tendon rupture is not high, but the continuous clinical case reports suggested a direct 
interaction between glucocorticoid injection and tendon rupture. In this study, it was 
hypothesized that glucocorticoids might have deleterious effect on the cell growth, 
proliferation and even on the extracellular matrix metabolism and finally led to 
tendon rupture. 
Scientific and medical literature addressing this concern is scant and is generally 
limited to the observed effects in animals. Although such researches started since 
1960，s, no consistent result has been concluded yet and the mechanism of 
glucocorticoid-induced rupture is poorly understood. It may be partially due to the 
fact that all the studies were worked on animal model, which may have different 
response to human and the direct cause-relationship could not drawn easily in this 
complicated situation. Also differences in selection and usage of drugs, experiment 
conditions and tissue source, led to non-conclusive results. Thus in the present study, 
the use of human tendon fibroblasts and in vitro system are more beneficial to 
ascertain the direct role of glucocorticoids in tendon disorder. 
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5.1 Dexamethasone and P D G F B B induced Change of Cell Morphology 
Cell shape has often been implicated in cell function (Folkman et al 1978). One of 
the major histological characteristics of fibroblasts in tendon is their typical spindle 
shape and oval-shaped nucleus. When confluence, fibroblasts display a parallel array. 
Within cell, biosynthesis of collagen fibrils takes place with the formation of 
collagen substance which gives rise to procollagen filaments. These make contact in 
parallel apposition to produce striated "spindle-shaped bodies" which elongate by the 
longitudinal attachment of more procollagen filaments and form intracellular nascent 
collagen fibrils (Santander et al 1999). This shape can be maintained or modulated in 
cell culture. Alternation of cell morphology might be correlated with synthesis of 
specific proteins such as actin which has been implicated in altering membrane shape 
and form (Heidemann et al 1999); and dynamin which can interact with the actin 
cytoskeleton to regulate actin reorganization and subsequently cell shape (McNiven 
et al 2000). 
In the present study, dexamethasone-treated fibroblasts became flattened, polygonal 
and diminished intercellular contacts. It is unclear what causes the phenotypic 
changes of fibroblasts in response to the glucocorticoids. When reviewing the past 
literature, few studies examined the morphological alternations of fibroblasts after 
glucocorticoids administration. For instance, one study on lung fibroblasts showed 
that dexamethasone had the ability to directly augment cell contractility in a 
concentration dependent manner (Skold et al 1999). Consistent with this, a study 
showed that glucocorticoids could induce increase in contractility in human lung 
fibroblasts by upregulation of filamentous actin (Miki et al 2000). In contrast, it was 
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showed that glucocorticoid did not alter cell morphology of human skin fibroblast, 
although cell proliferation and collagen secretion were both inhibited (Hein et al 
1988). 
In the current study, we postulated that decreased in collagen synthesis with thinner 
collagen fibril produced in dexamethaosone-treated fibroblasts might account for the 
flattened shape of cells. Moreover, the diminished intercellular contacts might be due 
to the decrease in proteoglycan synthesis which has been reported to participate in 
the adhesion process (Hardingham et al 1992). 
In contrast, PDGFBB has chemotactic activity for fibroblasts. Upon treatment with 
this growth factor, cells were stimulated for migration. This chemoattractant activity 
is not a general property of other growth factor such as fibroblast growth factor, 
epidermal growth factor or nerve growth factor (Seppa et al 1982). As shown in this 
study, fibroblasts grown in the presence of PDGFBB have more spindle-appearance 
characterized by branching processes and a compact cell body. This alteration in 
morphology may be due to the increase in number of actin fibers. In fact, PDGFBB in 
lOng/ml has been shown to induce elongated cell shape by changing the actin 
cytoskeleton in human fibroblasts (Hedberg et al 1995) and the actin fibers have been 
implicated in altering membrane shape and form during cell migration (McNiven et 
al 2000). Besides, PDGFBB has been shown to induce elongation and the formation 
of long processes by human dermal fibroblasts and this stimulation depends on a 
signaling pathway involving phosphatidylinositol 3-kinase (PI3K) (Ivarsson et al 
1998), which was necessary for actin polymerization (Heldman et al 1996). 
Moreover, adhesive proteins such as fibronectin apparently have an important role in 
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determining the basic phenotypic state of the cells. PDGFBB could enhance 
fibronectin levels by 43% in rat fibroblasts (Zhang and Lo 1995). And fibronectin 
could act as a carrier for PDGF to enhance cell replication (Roy et al 1993) or acts 
directly to stimulate phosphatidylinositol bisphosphate (PIP2) synthethsis, which 
plays a role in cytoskeleton regulation (McNamee et al 1993). 
Cell morphology changed from polygonal shape in dexamethasone-treated group to 
spindle shape in the mixed group, although some cells were still in polygonal 
appearance. The restoration of normal typical shape and increased the long possess 
reflected that PDGFBB could counteract the effect of dexamethasone on cell 
morphology. The change in cellular morphology is reversible by PDGFBB suggested 
that dexamethasone is not a cytotoxic drug, since cell death associated to cytotoxic 
drug is usually irreversible. 
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5.2 Dexamethasone Retarded Cell Growth of Human Tendon Fibroblast 
Numerous investigators have demonstrated the effect of glucocorticoids on different 
cell types. It has been suggested that different tissue respond differently to 
glucocorticoids (Pones et al 1977). In general, in skin (Pones et al 1977), muscle 
(Stewart et al 1995; Shin et al 2000), ligament (Yu et al 1999)，bone (Crofton et al 
2000) and lymphoid (Fukuzuka et al 2000; Migliorati et al 1994) tissue, effect of 
glucocorticoids is inhibitory; while in liver (Mizushima et al 2000) the response is 
mostly stimulatory. 
Therefore, the effects of glucocorticoids on human tissue, especially on tendon, are 
of particular interest, because of the clinical applications. But few worked on tendon 
fibroblasts, and to our knowledge, no other studies have examined the effect of 
glucocorticoids on the human tendon fibroblasts. 
In the current study, the effect of dexamethasone on viable cell number was 
evaluated by the MTT assay. In the presence of dexamethasone, viable cell number 
was markedly decreased when compared to the control group (Fig. 17). Besides, 
result from the flow cytometry showed a decrease in the fraction of cells in S phase 
in dexamethasone-treated group (Table.2). This means fewer cells were proliferated 
at that moment. Moreover, result from the BrdU incorporation assay revealed that 
dexamethasone could also decrease the rate of cell proliferation (Fig. 19). This anti-
proliferative effect was observed in all subjects tested (N=10). 
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The slower proliferation rate was in agreement with the prolonged doubling time of 
fibroblasts as estimated from the growth kinetic curve (Fig. 11). No distinguishable 
subdiploid peak was observed in flow cytometry and hence provided evidence that 
dexamethasone would not induce apoptosis. In conclusion, dexamethasone could 
inhibit cell growth in human tendon fibroblasts but did not exert cytotoxic effect on 
the cells. 
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5.3 Dexamethasone Inhibited Collagen Synthesis 
Fibroblasts are known to synthesize collagen fibrils and other matrix proteins. The 
development of an extracellular matrix is to protect cells and to bind them together in 
a spatial arrangement required for specialized anatomical and physiological functions. 
The tendon cells can synthesize the components of the tendon matrix, such as 
collagen, elastin fibers as well as proteoglycan. In general, the synthetic activity is 
high during growth and diminishes with age. However, the activity pattern may 
change drastically in many pathological conditions. 
In this study, collagen synthesis in human tendon fibroblasts was evaluated as the 
radioactive incorporation of H-proline. Dexamethasone at IjuM significantly 
inhibited collagen synthesis (p = 0.003，n=6) (Fig.23). This finding was in agreement 
with the study of Oxlund using rat in vivo model. They showed that glucocorticoid 
injection to rat limb would cause a progressive thinning and reduction in collagen of 
tendon (Oxlund H 1982). 
Other studies on different cell types also found inhibitory effect of glucocorticoids on 
collagen synthesis or mRNA production. For instance, a study using dexamethasone 
as a treatment of chronic lung disease of 14 infants found that infants treated with 
dexamethasone showed a marked decrease in whole body type I collagen synthesis 
and soft tissue collagen turnover (Crofton et al 2000). In 1997，Advani had 
demonstrated that injection of dexamethasone where into neonatal mice suppressed 
the ^H-proline incorporation in bone (Advani et al 1997). In vitro study showed that 
dexamethasone treatment of both chick skin and lung fibroblasts resulted in a 
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decrease of collagen synthesis (Sterling et al 1983). In human skin fibroblasts, 
production of collagen type I were reduced after glucocorticoid treatment (Hein et al 
1988; Oikarinen et al 1988). While Sim and his colleagues showed that 
dexamethasone markedly inhibited collagen biosynthesis in rat skin (Sim et al 1976). 
Another study further showed that the inhibitory effect of dexamethasone on 
collagen I synthesis was through a direct effect on the collagen gene promoter 
(Weiner et al 1987). However, another in vitro study found that under higher oxygen 
tension, dexamethasone could induce cell proliferation and collagen synthesis in 
human anterior cruciate ligament cells (Fermor et al 1998). 
In fact, collagen biosynthesis requires a wide spectrum of enzymes, these enzyme are 
all present in tendon cells while their activities depend on many other factors, such as 
hormones and surrounding physical stimuli (Karpakka et al 1992). Thus, other 
studies tried to account for the enzymatic reaction involved in such process. For 
instance, several studies demonstrated that glucocorticoids reduced the activity and 
level of prolyl hydroxylase, which was necessary for the intracellular hydroxylation 
for the formation of triple-helical collagen (Cutroneo et al 1975 and Oikarinen A 
1977). In addition, glucocorticoid was also shown to act indirectly on lysyl 
hydroxylase and lysyl oxidase which were responsible for post-transcriptional 
processing of collagen, such as catalyzing the cross-linking of collagen chains 
(Oikarinen et al 1988; Sterling et al 1983). Another protein called prolyl 4-
hydroxylase that catalyzes the post-translational modifications of collagen 
biosynthesis, was found to decrease in activity in Achilles tendon after 
glucocorticoid treatment in vivo (Karpakka et al 1992). These findings suggested that 
dexamethasone might inhibit collagen biosynthesis by inhibiting the enzymes 
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involved in the synthetic process and ultimately resulted in a decrease of collagen 
content. 
Factors determining the strength of connective tissues are complex, apart from the 
collagen metabolism, collagen fibril diameter is generally positively correlated with 
tissue strength. In the present study, evaluation of the size of collagen fibrils from the 
scanning electron microscope indicated that dexamethasone-treated fibroblasts have 
on the average thinner fibrils than the control group (Fig.22). Another histological 
and mechanical studies on the rat tendons showed that glucocorticoid administration 
with or without exercise increased the stiffness of the tendons and decreased the 
elongation (Inhofe et al 1995 and Miles et al 1992); disrupted the collagen fibrils and 
organization (Michna et al 1986); and caused tendons to reach their breaking strain 
earlier (Wood et al 1988). 
Besides the collagen metabolism and fibrils diameter, post-translational 
modifications of the collagen network (such as the formations of crosslinks between 
adjacent collagen molecules) are important determinants of the physicochemical 
properties of the extracellular matrix (Nimni ME 1983). Crosslinking could increase 
the stiffness of the collagen fibrils. In the recent study, SEM showed abnormality 
morphology of tendon fibroblast in the presence of dexamethasone, with thinner and 
irregular fiber outlines. 
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Therefore, the fine fibrils together with the lower ^H-proline incorporated into tendon 
fibroblasts after dexamethasone administration may account for the weakness of the 
mechanical properties of tendon. Also, the change in collagen network might affect 




5.4 Dexamethasone Inhibited Proteoglycan Synthesis 
Although the mechanical strength of tendon depends mainly on the collagen in the 
tendon (Oxlund H 1980)，proteoglycans are also related to the mechanical properties 
of connective tissues. Proteoglycans, which are present outside the fibrils, have 
refined functions in connective tissues such as assembly of collagen fibers, 
interactions between cell and matrix, functions as growth factor co-receptor and cell 
proliferation. The extracellular matrix contain GAGs or proteoglycans which fill the 
interfibrillar space and complement the role of collagen by retaining water in the 
tissue and controlling its flow. In tendon, the most abundant proteoglycan is 
dermatan sulfate, which can interact with several ECM molecules, such as collagen 
type I, VI and XIV (Ruoslahti E 1989; Takahashi et al 1993; Font et al 1993). 
Besides, one small leucine-rich proteoglycan, decorin, was shown to disrupt the 
collagen fibril of tendon in mice (Danielson et al 1997). These showed that 
proteoglycans play important functions in connective tissue. 
Proteoglycan metabolism in most cells is a highly regulated dynamic process that 
contributes directly to cell and tissue functions. In normal state, constant 
concentration of proteoglycans is maintained in a particular compartment over time. 
Cells in mature connective tissues devote a large proportion of their metabolic energy 
to proteoglycan synthesis. Catabolism of proteoglycans is also very active. The half-
life of proteoglycans in extracellular matrix can range from a few days to few weeks. 
Connective tissue cells such as tendon can alter their metabolism of proteoglycan in 
response to changes in biomechanical stimuli and remodel their extracellular matrix. 
In the present study, proteoglycan synthesis was measured using radioactive 
^^sulfate-incorporation method. Tendon fibroblasts cultured with dexamethasone 
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(1|LIM) have significantly decrease in proteoglycan synthesis (p= 0.004, n=8) (Fig.24). 
Similar study on the human skin fibroblasts showed that glucocorticoid treatment not 
only reduces the quantity of various glycosaminoglycans but also changes the 
distribution, the relative proportion, and the structure of connective tissue 
proteoglycans (Samstrand et al 1982). However, in another cell types, 
dexamethasone has also been shown to increase heparan sulfate proteoglycan core 
protein content of glomerular epithelial cells (Kasinath et al 1990). However, when 
examining the effect of glucocorticoid on articular cartilage, inconsistency results 
were obtained. For instance, one study using a dog model showed that glucocorticoid 
injection on articular cartilage would not affect the net rate of proteoglycan synthesis 
(Smith et al 1997). And an inhibitory effect of glucocorticoids on proteoglycan 
synthesis was also found in mice cartilage (Weiss et al 1986), but stimulation in 
rabbit costal chondrocyte cultures (Kato et al 1985). Also, another study using mouse 
articular cartilage found that glucocorticoid could stimulate proteoglycan synthesis 
(Behrens et al 1976; Verschure et al 1994). 
Nevertheless, the inhibitory effect on both collagen and proteoglycan synthesis in 
dexamethasone-treated cultures in this study indicated that it may suppress the 
synthesis of the matrix macromolecules, thereby preventing the replacement of 
matrix that was lost because of normal degradation. With time, this damages the 
tissue and predisposes to tissue weakening. 
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To understand the counteraction of dexamethasone and PDGFBB on tendon 
fibroblasts, cells were co-incubated with both substrates. PDGFBB is so-called 
"broad-range growth factor” that affects the proliferation of many cell types. 
Moreover, PDGF (8ng/ml) was shown to stimulate proliferation, as assessed by 
tritiated thymidine uptake, on human skin fibroblasts (Peterson et al 1994). It has 
been proved to be stimulator for tendon DNA synthesis or proliferation (Stein LE 
1985; Banes et al 1995; Spindler et al 1996). 
In the present study, cultures supplied with PDGFBB (lOng/ml) have higher 
proliferation rate by promoting more cells to enter the S phase of cell cycle (Table.2). 
As a result, viable cell number significantly increased when compared to the control 
group (Fig. 18). Besides, collagen and proteoglycan productions were markedly 
increased by PDGFBB (Fig.23 and Fig.24). In fact, a previous study has also shown 
that PDGFBB stimulated collagen type I expression in rat patellar tendon (Chan B P 
1998) and in human dermal fibroblasts (Ivarsson et al 1998). Thus, the data presented 
here clearly shown that this growth factor had anabolic effects on human tendon 
fibroblasts in vitro. 
In the combined treatment, PDGFBB could restore the depressed levels of viable cell 
number, cell proliferation, collagen and proteoglycan syntheses, in dexamethasone-
treated cultures. Although we have not studied the mechanism, this counteraction of 
PDGFBB may thus actually reflect protective effect against catabolic effects of 
dexamethasone on tendon fibroblasts. 
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Similar to this study, another group of researchers tried to correlate the interaction 
between these two substances. They found that dexamethasone (10nM-20|aM) could 
reduce baseline human skin fibroproliferation (Peterson et al 1994). When cultured 
the fibroblasts with both dexamethasone and PDGFBB, the presence of 
dexamethasone (20|aM) did not affect PDGF-driven fibroproliferation. Therefore 
they suggested that baseline proliferation be mediated by factors other than PDGF，or 
alternatively they are in distinct signaling pathways. The inconsistent finding of 
fibroblasts cultured with dexamethasone and PDGFBB together, may be due to tissue 
difference (tendon verses skin). 
Although a detailed discussion of these mechanisms is beyond the scope of this study, 
it should be mentioned that the deleterious effect dexamethasone on tendon fibroblast 
metabolism, at least in part, could be compensated by PDGFBB. 
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5.6 Expression of PDGF-P Receptor is regulated by dexamethasone and 
P D G F B B 
PDGF receptors are expressed on cells in vitro. Fibroblasts express both types of 
receptors (a and p)，but the level of P-receptor expression is higher that that of the a -
receptor (Westermark and Sorg 1993). The level of PDGF receptor expression has 
shown to be influenced by a number of factors. For instance, PDGF a-receptor 
expression on human foreskin fibroblasts decreased after exposure to transforming 
growth factor-p (TGF-P) (Gronwald et al 1989). Another similar study on skin 
showed that a significant reduction in PDGF-P receptor mRNA level not only in 
wounds, but also in nonwounded skin of dexamethasone-treated mice as well as in 
vitro in cultured skin-derived cells, demonstrating that direct effects of 
glucocorticoids on these genes are also important (Beer et al 1997). In contrast, 
PDGF-p receptor level was not affected by dexamethasone in muscle cells (Giorgino 
et al 1995). However, effect of glucocorticoids on tendon fibroblasts is poorly 
studied. 
In this study, it was hypothesized that the inhibitory effect of dexamethasone on cell 
growth of tendon fibroblasts might through the reduction of the growth factor 
receptor expression and hence to affect the normal cell metabolism. On the other 
hand, PDGFBB could counteract the inhibitory effects of dexamethasone by up 
regulating the receptor expression. 
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From the result of immunocytochemistry of PDGF-P receptor, dexamethasone-
treated group (Fig.25b) showed a weaker staining than the control group (Fig.25a). 
The result reflected this glucocorticoid could decrease the expression of PDGF-P 
receptor in human tendon fibroblasts. 
In contrast, PDGFBB-treated fibroblasts have a strong staining on the P-receptor 
expression indicating that PDGFBB could up regulate P D G F - P receptor expression in 
tendon cells. Indeed, it is well known that PDGF-P receptor can be up regulated by 
PDGF itself (Guha et al 1995; Langerak et al 1996). We postulated that the inhibitory 
effect of dexamethasone might regulate PDGF-p receptor expression and this might 
be a common pathway of dexamethasone and PDGFBB in regulating the cell 
metabolism. 
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5.7 Limitations of This Study 
5.7.7 Not enough sample to differentiate different between two sexes 
Since dexamethasone is a kind of steroid, receptor number per cell and cellular 
response to the steroid might not be the same. Tendon fibroblasts obtained from 
different sex might affect the result. ACL rupture is more common in males, possibly 
reflecting the greater prevalence of males than females who are involved in sports, 
although there may be other as yet unrecognized factors. Thus, in practice, it is 
difficult to obtain equal number of tendons from different sex group. Therefore, rat 
patellar tendons from both sexes were used to compare the result. From the result of 
rat patellar tendon fibroblasts, no statistically significant difference in viable cell 
number was shown among two-sex group (Fig. 14). Moreover, the percentages of 
viable cell number detected from rat fibroblasts and human fibroblasts were similar 
when fibroblasts cultured in lOOjiiM dexamethasone. Therefore we hypothesis that 
the sex did not have a great role in accounting the effect of glucocorticoid on tendon. 
5.7,2 Small sample size and few assays 
In this study, we need to obtain healthy human tendon specimen from the ACL 
reconstruction surgery. This was the first limitation to obtain large amount of sample 
within this two years. Besides, only cell passages 1-3 of the primary cultures could 




5.7.3 Limitations of the cell culture model 
Although cell culture system could provide a homogenous environment to examine 
the direct effect of the substance, certain limitation should be remanded. In cell 
culture level, the nature three-dimensional structure would be lost and monolayer 
cultures do not experience the mechanical stimulus of three-dimensional tension as in 
vivo. Therefore, the magnitude and time of the cellular response may vary in a great 
deal. 
5.7.4 Difficult to further in vivo study on human 
From the results of the study, it clearly showed the direct deleterious effects of 
dexamethasone on human tendon fibroblasts. However, further investigation of in 
vivo effect on human is difficult. 
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5.8 Contributions of This Study 
5,8,1 Overcome the limitation of the past research 
5.8.1.1 Human tendon specimen 
In the current study, primary cell culture from human patellar tendon was used for 
the examination. This can eliminate the different responses between animal and 
human, and such results were more relevant to the clinical practice. 
5.8.1.2 In vitro system 
As mentioned before, past studies on in vivo model could not elucidate the etiology 
of tendon disorder after glucocorticoids administration. It is difficult to conclude 
whether the incidence of tendon rupture was due to the drug itself, the micro-trauma 
created from the injection, or some other unknown reasons. In vitro model, on the 
other hand, could clearly define the role of glucocorticoid in tendon disorder. 
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5.8.2 Understand the effect of dexmaethasone on human tendon fibroblasts 
This is the first illustration on the direct effects of glucocorticoid on human tendon 
fibroblasts. With the results from this study, we can clarify the link between 
glucocorticoid injection and tendon disorders. Recommended therapeutic usage of 
this drug could be drawn with further investigated. 
5.8.3 Counteract the deleterious effects of dexamethasone by PDGFBB 
The use of PDGFBB in this study has successfully demonstrated that this may be a 
possible protective way to allow the continuous use of this useful regime 
(glucocorticoid administration) by limiting its adverse side effects on tendon. 
Although we have not determined the mechanism of their interaction, PDGFBB has 
counteracted the inhibitory effects of dexamethasone in all parameters we have 
examined. Therefore, it may be a possible solution of this clinical problem. 
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6.1 Conclusion 
6.2 Future study 
6.2.1 Study the balance between matrix synthesis and degradation 
6.2.2 Determine collagen typing 
6.2.3) Further explore the effect of glucocorticoid in organ culture model 
6.2.4 Investigate cellular mechanism of dexamethasone and PDGFBB 
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6.1 Conclusion 
This study has investigated the hypothesis that glucocorticoid (dexamethasone), 
significantly influenced the cellular metabolism and matrix syntheses of human 
tendon fibroblasts. On the other hand, PDGFBB could counteract these inhibitory 
effects of dexamethasone. In vitro effects of dexamethasone and PDGFBB on human 
tendon fibroblasts were summarized in Table 3. 
TREATMENT 
Dexamethasone P D G F B B Dexamethasone + P D G F B B 
1. viable cell number Inhibitory Stimulatory Similar to the control 
2. Rate of proliferation Inhibitory Stimulatory Similar to the control 
3. Number of proliferating cell Inhibitory Stimulatory Similar to the control 
4. Apoptosis No effect No effect Similar to the control 
5. Collagen synthesis Inhibitory Stimulatory Similar to the control 
(not significant) 
6. Proteoglycan synthesis Inhibitory Stimulatory Similar to the control 
7. PDGF-p receptor expression Inhibitory Stimulatory Similar to the control 
Table 3. A summary of/w vitro effects of dexemathasone and P D G F B B on human 
tendon fibroblasts. 
This was the first time to elucidate the direct cellular effect of glucocorticoid on 
human tendon fibroblasts, more research on this field would help to correlate the 
incidence of tendon rupture after glucocorticoid administration and provide a 
medical guideline for such regime. 
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6.2 Future Study 
In order to fully establish the cause-effect relationship of glucocorticoid to tendon 
rupture, the following three aspects are suggested for ftirther investigations. 
6.2,1 Study the Balance between Matrix Synthesis and Degradation 
A balance between the synthesis and degradation of extracellular matrix (ECM) 
components is crucial for normal development and growth as well as for the repair 
and maintenance of proper tissue architecture. The maintenance of normal tendon 
function depends on a balance between catabolic and anabolic fibroblast metabolism. 
Although the amount of collagen and proteoglycan synthesis has been determined in 
this study, their degradation has not been examined. An increased collagen turnover 
or a decreased collagen synthesis would predispose the tendon to rupture. And these 
changes are of functional significance in tendons. In addition, physical properties of 
different tissues depend on the ratio of collagen to proteoglycan, because 
proteoglycans are important in regulating collagen metabolism (Danielson et al 
1997). 
Collagen degradation by matrix metalloproteinases (MMPs) can be measured by 
zymography with gelatin (Guarda et al 1993). Proteoglycan breakdown can be 
measured by colorimetric method using proteinase K which digests proteoglycans to 
sulfated glycosaminoglycan. The amount of sulfated glycosaminoglycan can be 
detected by colorimetric assay using dimethylmethylene blue (Handley et al 1995). 
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6,2.2 Determine Collagen Typing 
The proper function of a tendon depends on the appropriate type, synthesis, assembly, 
crosslinking, and remodeling of collagen. The amount of collagen bundles and the 
individual types of collagen influences the ability of the tendon to withstand tensile 
force during loading. Normal tendon consists almost entirely of type-I collagen, a 
ruptured tendon also contains a substantial proportion of type-Ill collagen. 
Fibroblasts from ruptured tendons produce both type-I and type-Ill collagens on 
culture. It is known that type I collagen imparts a great mechanical strength to tendon 
and type-Ill collagen is less resistant to tensile forces. Therefore, inappropriate and 
persistent synthesis of type III collagen may substantially weaken the tendon matrix 
and predispose tendon to spontaneous rupture. In the current study, total collagen 
synthesis was measured. However, determination of changes of collagen typing after 
glucocorticoid treatments is of value for further understanding the change that 
characterize tendon rupture. 
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6.2.3 Further Explore the Effect of Glucocorticoid in Organ Culture Model 
The current study showed a direct cellular response of human tendon fibroblasts 
towards dexamethasone and PDGFBB in monolayer culture. However, the loss of 
nature three-dimensional structure in this cell culture system might not be truly 
represents the real in vivo situation. Thus, the importance of this nature matrix 
condition should be further investigated. Besides, the dosages of dexamethasone 
examined in this study were based on the reference from the past in vitro studies. 
This concentration may not have the same effect in vivo. Generally, organ culture 
model is the best way to target this problem, in which the three-dimensional structure 
of tendon can be preserved. Therefore, organ culture will be performed in the future. 
6.2.4 Investigate Molecular Mechanism of Dexamethasone and PDGFBB 
Despite years of clinical use and ongoing research, however, the mechanism of 
action of glucocorticoid is not yet clarified. Only recently has advanced 
understanding of the broad range of actions of glucocorticoids within the immune 
system (Sha WC 1998; Barnes et al 1997) been made. Apart from these, much 
remains unresolved such as the molecular mechanism that accounts the inhibitory 
effect of glucocorticoid on fibroblast proliferation. Until recently, one study showed 
this inhibitory effect was due to induction of in mouse L929 fibroblasts 
(Ramalingam et al 1997). Therefore, more information on the mechanism of action 
of dexamethasone and its relationship to PDGF is necessary before the mechanism of 
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